<!DOCTYPE html>
<!--[if IE 7]>                  <html class="ie7 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if lte IE 8]>              <html class="ie8 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--> <html class="not-ie no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">  <!--<![endif]-->
<head>
  <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="shortcut icon" href="https://aspe.hhs.gov/sites/default/files/Favicon2.png" type="image/png" />
<meta name="description" content="U.S. Department of Health and Human Services Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort Barbara Gage, Ph.D., The MEDSTAT GroupThy Dao, The Urban Institute March 2000 PDF Version: http://aspe.hhs.gov/daltcp/reports/2000/96useexp.pdf (35 PDF pages)" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://aspe.hhs.gov/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" />
<link rel="shortlink" href="https://aspe.hhs.gov/node/66546" />
<meta property="og:site_name" content="ASPE" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://aspe.hhs.gov/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" />
<meta property="og:title" content="Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort" />
<meta property="og:description" content="U.S. Department of Health and Human Services Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort Barbara Gage, Ph.D., The MEDSTAT GroupThy Dao, The Urban Institute March 2000 PDF Version: http://aspe.hhs.gov/daltcp/reports/2000/96useexp.pdf (35 PDF pages)" />
<meta property="og:updated_time" content="2017-02-21T11:35:18-05:00" />
<meta property="article:published_time" content="2015-12-09T05:21:53-05:00" />
<meta property="article:modified_time" content="2017-02-21T11:35:18-05:00" />

  <title>Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort | ASPE</title>
	<meta http-equiv="X-UA-Compatible" content="IE=edge"><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1026.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>

	<!-- Mobile Specific Metas
	================================================== -->
	<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=0">

  <link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__5ln8neBOcJfyUveiD4y9fhI6kHBLOQ_YL0mMC-LS9a0__TPJIZT9UBnf_685NlFTJ5KnZVsjwFk6ACQ-nwwygmwU__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__ng49uRH5y4Hl9VF9hHW_vXOj-mcOc2u2ShJqJ1YKIGU__FoMCD14GBvZaRiqSQ_JpP1w3rDB21n7H2Ar4pRZaIh8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__Hskudx14OJ5Hz8vqU7CUgN6SDV5rINZuEq9VuGsSeyc__EwNIl3xeFrniW2TmonovTzhSs3X5MdFps210puE7jog__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__9rZoaX9BdzjjNucvYxduxeNAVO2zgW_Rvjhb5rq5whc__lSr_y16grDSgHf4booPChnF7QXz3TQY3hafH49twE0k__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__ZgfI_ZPib5yVY0o5aKo_6TFn946Tuu_nFDa0ySTmkSc__2FTFrNw2eNh0mpHIOA34r6YRwBZMm2PjJ_JubnwLigg__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__dxabpJ5rQgDSixKgLJZjWc1beC6mpROKwVrmWxI5eno__rqhz_hGsE_i59O7-W991o71_Jxw1QOtGMxn4nsOLHY8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="/sites/default/files/advagg_css/css__ZbRCq2NqWgK-HXAQI3So0N1n0nr4HonsJS3eQuuxukw__7Olkk8Locn8Dj0eR0Ww3rbV9lks9sxipcboMXB18RRs__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />

	<!-- Head Libs -->
	<script src="/sites/all/themes/stability/stability_aspe/vendor/modernizr.js"></script>

	<!--[if lt IE 9]>
		<script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
		<script src="/sites/all/themes/stability/vendor/respond.min.js"></script>
	<![endif]-->

	<!-- Favicons
	================================================== -->
	<link rel="apple-touch-icon" href="/sites/all/themes/stability/images/apple-touch-icon.png">
	<link rel="apple-touch-icon" sizes="72x72" href="/sites/all/themes/stability/images/apple-touch-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="114x114" href="/sites/all/themes/stability/images/apple-touch-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="144x144" href="/sites/all/themes/stability/images/apple-touch-icon-144x144.png">

</head>
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-66546 node-type-basic-report">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-JLFR"
                  height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
  })(window,document,'script','dataLayer','GTM-JLFR');</script>
<!-- End Google Tag Manager -->
  <div id="skip-nav" class="accessibility_menu">
    <strong>Shortcut Navigation:</strong>
    <ul>
      <li><a href="#content" accesskey="c" title="Skip to page content (ctrl/alt + c)">Page Content</a></li>
      <li><a href="#nav" accesskey="m" title="Skip to main navigation menu (ctrl/alt + m)">Site Navigation</a></li>

      <li><a href="#Footer" accesskey="f" title="Skip to footer (ctrl/alt + f)">Footer</a></li>
    </ul>
  </div>

    
<div class="site-wrapper">
  
  <header class="header header-menu-fullw header-top-clean">
    <div id="brand-bar">
        <div class="container">
                    <img alt='bird' src="/sites/all/themes/stability/stability_aspe/images/bird.png"> <a target="blank" tabindex="4" href="http://www.hhs.gov/">U.S. Department of Health & Human Services</a>
        </div>

    </div>
    <div class="header-main">
        <div class="container clearfix">
            <div class="social-links-wrapper">
                <ul class="social-links social-links__light">
                                                          <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="/sites/all/themes/stability/stability_aspe/images/tw.png"/></a></li>
                                    <!--                  --><!--                    <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin.png"/></a></li>-->
<!--                  -->
                                                                      </ul>
            </div>
            <!-- Logo -->
            <div class="logo">
                                <div class="site_name_wrapper">
                                     <span class="h1">
                                      <a href="/">ASPE</a>
                                       </span>
                                  <p class="tagline"><p>Office of The Assistant Secretary</p><p> for Planning and Evaluation</p></p>
                    </div>
            </div>
            <!-- Logo / End -->
            <div class="header_right_wrapper">
                <div class="search-form">
                    <form action="/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline">
  <div class = "input-group"><div class="form-type-textfield form-item-search-block-form form-item form-group">
  <label class="element-invisible" for="edit-search-block-form--2">Search </label>
 <input title="Enter the terms you wish to search for." placeholder="Search Site..." class="form-control form-control form-text" type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions--2"><input class="btn btn-primary btn-icon form-submit" type="image" id="edit-submit" name="submit" value="Search" src="https://aspe.hhs.gov/sites/all/themes/stability/stability_aspe/images/search-white2.png" alt="Search" title="Search" /></div></div><input type="hidden" name="form_build_id" value="form-HuBR56FrDNQiWM2PE3bpshGJ4MlYBZFadMAn0BvfJh0" />
<input type="hidden" name="form_id" value="search_block_form" />
</div>
</div></form>                </div>
                <button type="button" class="navbar-toggle" value="Menu">
                    <i class="fa fa-bars"></i>Menu
                </button>
            </div>

        </div>
    </div>

    <!-- Navigation -->
    <nav id="nav" class="nav-main">
        <div class="container">
          <ul data-breakpoint="767" class="flexnav">
                <li class="first expanded"><a href="/basic-search/about" title="">About</a><ul><li class="first leaf"><a href="/mission" title="">Mission</a></li>
<li class="leaf"><a href="/key-staff" title="">Leadership</a></li>
<li class="leaf"><a href="https://www.usajobs.gov/" title="">Careers</a></li>
<li class="expanded"><a href="/coordination" title="linkTo">Coordination</a><ul><li class="first leaf"><a href="/evaluation-evidence" title="">Evaluation &amp; Evidence</a></li>
<li class="leaf"><a href="/national-alzheimers-project-act">National Alzheimer&#039;s Project Act</a></li>
<li class="leaf"><a href="/health-and-human-services-hhs-data-council">HHS Data Council</a></li>
<li class="last leaf"><a href="/national-committee-vital-and-health-statistics" title="National Council on Vital and Health Statistics">National Council on Vital and Health Statistics</a></li>
</ul></li>
<li class="expanded"><a href="/basic-search/divisions" title="">Offices</a><ul><li class="first leaf"><a href="/office-disability-aging-and-long-term-care-policy-daltcp">Disability, Aging, and Long-Term Care Policy</a></li>
<li class="leaf"><a href="/office-health-policy-hp">Health Policy</a></li>
<li class="leaf"><a href="/office-human-services-policy">Human Services Policy</a></li>
<li class="last leaf"><a href="/office-science-and-data-policy">Science and Data Policy</a></li>
</ul></li>
<li class="leaf"><a href="/strategic-planning" title="Strategic Planning">Strategic Planning</a></li>
<li class="last leaf"><a href="/contact-aspe" title="">Contact ASPE</a></li>
</ul></li>
<li class="expanded"><a href="/basic-search/topics" title="">Topics</a><ul><li class="first leaf"><a href="/affordable-care-act-research">Affordable Care Act Research</a></li>
<li class="leaf"><a href="/alzheimers-dementia">Alzheimer&#039;s / Dementia</a></li>
<li class="leaf"><a href="/early-childhood">Early Childhood</a></li>
<li class="leaf"><a href="/incarceration-reentry">Incarceration &amp; Reentry</a></li>
<li class="leaf"><a href="/opioid-abuse-us-and-hhs-actions-address-opioid-drug-related-overdoses-and-deaths" title="Opioids">Opioids</a></li>
<li class="leaf"><a href="/patient-centered-outcomes-research-trust-fund">Patient-Centered Outcomes Research Trust Fund (PCORTF)</a></li>
<li class="expanded"><a href="/basic-search/poverty" title="">Poverty</a><ul><li class="first leaf"><a href="/poverty-guidelines">Poverty Guidelines</a></li>
<li class="last leaf"><a href="/poverty-estimates-trends-and-analysis">Poverty Analysis</a></li>
</ul></li>
<li class="leaf"><a href="/teen-pregnancy-prevention">Teen Pregnancy Prevention</a></li>
<li class="leaf"><a href="/homelessness">Homelessness</a></li>
<li class="last leaf"><a href="/medicare-access-and-chip-reauthorization-act-2015">MACRA</a></li>
</ul></li>
<li class="leaf"><a href="/reports" title="">Publications</a></li>
<li class="last expanded"><a href="/basic-search/datasets" title="">Data and Tools</a><ul><li class="first last leaf"><a href="/evaluations" title="">Evaluation Database</a></li>
</ul></li>
            </ul>
        </div>
    </nav>
    <!-- Navigation / End -->
</header>  <div class="main" role="main">
    <!--PAGEWATCH CODE="USHHS_458"-->
    <section class="page-heading">
  <div class="container">
    <div class="row">

        <div class="col-md-6">
                <h1>
                    
          Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort        </h1>
                                 <p class="author">
                                                 <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2000-03-01T00:00:00-05:00">03/01/2000</span>               
                           </p>


                  </div>


        <div class="col-md-6">
           <ul class="breadcrumb"><li class="first"><a href="/" title="Home">Home</a></li>
<li class="last">Medicare's Hospice Benefit: Us...</li>
</ul>        </div>


    </div>
  </div>
</section>
    
      <div  class="nd-region nd-region-filter">
  
       

    
      <div  id="Filter" class="row">     

        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region nd-region-similar-content">
  
       

    
      <div  id="Similar-Content" class="row">     

        
                  
        
                                    <div  id="top" class="">
                          
                              <div id="block-views-2100ccfdd214bdbcf634d7e4832c265b" class="widget block block-views solr-similar-content" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Similar</span> content</h3>
		</div>
    
  <div class="view view-similar-content-solr view-id-similar_content_solr view-display-id-block_solr_similar_content view-dom-id-8d8788fd30c56ec0ec4ce368e6744e7e">
        
  
  
      
    
    <span class="field-content"><a href="/basic-report/synthesis-and-analysis-medicares-hospice-benefit-executive-summary-and-recommendations">Synthesis and Analysis of Medicare&#039;s Hospice Benefit: Executive Summary and Recommendations</a></span>    
    <span class="field-content"><a href="/basic-report/hospice-benefits-and-utilization-large-employer-market">Hospice Benefits and Utilization in the Large Employer Market</a></span>    
    <span class="field-content"><a href="/basic-report/medicares-hospice-benefit-revising-payment-system-better-reflect-visit-intensity">Medicare&#039;s Hospice Benefit: Revising the Payment System to Better Reflect Visit Intensity</a></span>    
    <span class="field-content"><a href="/execsum/important-questions-hospice-next-century">Important Questions for Hospice in the Next Century</a></span>    
    <span class="field-content"><a href="/basic-report/outcomes-and-utilization-hospice-and-non-hospice-nursing-facility-decedents">Outcomes and Utilization for Hospice and Non-Hospice Nursing Facility Decedents</a></span>  
  
  
  
  
  
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Content">     

        
                  
        
                  
        
                  
        
                                    <div  class="col-md-12 " id="content">
                          
                              <div id="block-aspe-aspe-addthis" class="widget block block-aspe" >
  
      
  <div class="clearfix">
  <ul class="addthis_sharing_toolbox node-share__links" data-url="https://aspe.hhs.gov/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" data-title="Medicare&#039;s Hospice Benefit: Use and Expenditures, 1996 Cohort">
    <li><a class="addthis_button_print"><img src="https://aspe.hhs.gov/sites/all/themes/stability/stability_aspe/images/print-white.png" alt="print" /></a></li>
    <li><a class="addthis_button_email"><img src="https://aspe.hhs.gov/sites/all/themes/stability/stability_aspe/images/mail-white.png" alt="email" /></a></li>
    <li><a class="addthis_button_twitter"><img src="https://aspe.hhs.gov/sites/all/themes/stability/stability_aspe/images/tw.png" alt="twitter" /></a></li>
<!--    <li><a class="addthis_button_facebook">--><!--</a></li>-->
    <li><a class="addthis_button_compact"><img src="https://aspe.hhs.gov/sites/all/themes/stability/stability_aspe/images/plus-white.png" alt="compact" /></a></li>
  </ul>
</div>

  </div> <!-- /.block -->

                
    
  
  <div class="content clearfix node-basic-report">
    <p><font><b><font face="Calisto MT">U.S. Department of Health and Human Services</font></b></font></p>
<h1>Medicare's Hospice Benefit: Use and Expenditures, 1996  		Cohort</h1>
<h3>Barbara Gage, Ph.D., The MEDSTAT GroupThy Dao, The Urban  		Institute</h3>
<h3>March 2000</h3>
<p>PDF Version:  		<a href="/system/files/pdf/73406/96useexp.pdf">http://aspe.hhs.gov/daltcp/reports/2000/96useexp.pdf</a>  		(35 PDF pages)</p>
<hr /><blockquote>
<p><i>This report was prepared under contract #100-97-0010 between the  		  U.S. Department of Health and Human Services (HHS), Office of Disability, Aging  		  and Long-Term Care Policy (DALTCP) and the Urban Institute. For additional  		  information about this subject, you can visit the DALTCP home page at  		  <a href="http://aspe.hhs.gov/_/office_specific/daltcp.cfm">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a> or contact the ASPE Project  		  Officer, Jennie Harvell, at HHS/ASPE/DALTCP, Room 424E, H.H. Humphrey Building,  		  200 Independence Avenue, S.W., Washington, D.C. 20201. Her e-mail address is:  		  <a href="mailto:Jennie.Harvell@hhs.gov">Jennie.Harvell@hhs.gov</a></i></p>
<p><i>This report was prepared for the Office of Disability, Aging and  		  Long-Term Care Policy in the Office of the Assistant Secretary for Planning and  		  Evaluation, US Department of Health and Human Services under contract to the  		  Urban Institute. The project officers were Jennie Harvell, ASPE and Carol  		  Blackford, Health Care Financing Administration.</i></p>
<p><i>The opinions and views expressed in this report are those of the  		  authors. They do not necessarily reflect the views of the Department of Health  		  and Human Services, the contractor or any other funding organization.</i></p>
</blockquote>
<hr /><h2>TABLE OF CONTENTS</h2>
<dl><dt><a href="#section1">INTRODUCTION</a></dt>
</dl><dl><dt><a href="#section2">DATA AND METHODS</a></dt>
<dd>Sample</dd>
<dd>Variables</dd>
</dl><dl><dt><a href="#section3">ANALYSIS</a></dt>
<dd>Who Uses Medicare's Hospice Benefit?</dd>
<dd>Hospice Utilization Patterns</dd>
<dd>Hospice Expenditures</dd>
<dd>Medicare Expenditures and Service Use Prior to Hospice  		  Enrollment</dd>
<dd>HMO Enrollees and Dual-Eligible Populations</dd>
<dd>Multivariate Results Predicting Hospice Payments and Utilization  		  Levels</dd>
</dl><dl><dt><a href="#section4">CONCLUSION</a></dt>
<dd>Limitations and Data Constraints</dd>
</dl><dl><dt><a href="#section5">SUMMARY</a></dt>
</dl><dl><dt><a href="#references">REFERENCES</a></dt>
</dl><dl><dt><a href="#notes">NOTES</a></dt>
</dl><dl><dt>LIST OF TABLES</dt>
<dd><a href="#table1">TABLE 1</a>. Characteristics of Medicare Hospice  		  Users</dd>
<dd><a href="#table2">TABLE 2</a>. Top 10 Primary Diagnoses in  		  Hospice</dd>
<dd><a href="#table3">TABLE 3</a>. Hospice Expenditures and Utilization  		  by Number of Benefit Periods Utilized</dd>
<dd><a href="#table4">TABLE 4</a>. Share of Cases by Number of Hospice  		  Benefit Periods Utilized or Those Ending in Death, by Primary Diagnosis</dd>
<dd><a href="#table5">TABLE 5</a>. Medicare Hospice Expenditures and  		  Utilization</dd>
<dd><a href="#table6">TABLE 6</a>. Hospice Use Levels by Type of Hospice  		  Service</dd>
<dd><a href="#table7">TABLE 7</a>. Mean (and Median) Hospice Expenditures  		  and Utilization by Primary Diagnosis</dd>
<dd><a href="#table8">TABLE 8</a>. Georgraphic Variation in Hospice  		  Expenditures and Utilization</dd>
<dd><a href="#table9">TABLE 9</a>. Select Medicare Expenditures in 6  		  Months Prior to First Hospice Enrollment by Primary Diagnosis</dd>
<dd><a href="#table10">TABLE 10</a>. Medicare Hospice Expenditures and  		  Utilization by Select Characteristics</dd>
<dd><a href="#table11">TABLE 11</a>. OLS Regression Results Predicting  		  Medicare Hospice Expenditures and Days Utilized</dd>
</dl><h2><a name="section1" id="section1">INTRODUCTION</a></h2>
<p>This report presents information on Medicare's hospice benefit -- who is  		using it, how it is being used, what costs are associated with its use, what  		costs precede hospice enrollment and how these vary by type of enrollee. This  		information will be important for understanding the role of Medicare's hospice  		benefit in the context of the other benefits Medicare provides to one of the  		program's most expensive populations -- the terminally ill -- and understanding  		whether the current policies meet the needs of the population enrolling in  		hospice. Also included are snapshot contrasts of two groups of enrollees --  		those who were enrolled in HMOs or on Medicaid at least once during the 12  		months between July 1995 and July 1996.</p>
<p>This report is intended to provide background information on the overall  		Medicare hospice population. ASPE originally initiated this study to better  		understand the use of hospice by dually-covered hospice enrollees in nursing  		facilities and this report provides the contrast for the nursing facility-based  		enrollee discussed in the two next reports in this study. Questions have been  		raised about whether hospice patients who live in nursing facilities are on the  		benefit for a longer time, receive different services, or otherwise use it  		differently than those residing in the community. This report describes the  		benefit's use by all enrollees in 1996.</p>
<p>Hospice is not a widely-used benefit. Medicare insures over 38 million  		beneficiaries; almost 88 percent are 65 years or older. Only five percent of  		the aged beneficiaries died in 1996 and only about 18 percent of them were  		enrolled in hospice prior to death.</p>
<p>Hospice is also a different kind of benefit. The expected outcome is  		death rather than restoration of health. The "treatment" goal is to manage the  		patients' dying process and provide counseling and bereavement services to the  		patient and family members instead of curing the patient. Hospice providers  		apply different standards for managing pain and other symptoms than are typical  		in acute care. This, along with the greater emphasis on integrated care  		management, more extensive personal care services, and the spiritual counseling  		that is provided to enrollees prior to death and to family members prior to and  		for a year following death, distinguishes the hospice benefit from other  		Medicare benefits. Beneficiaries have to waive their right to other  		Medicare-covered treatments for their terminal illness to receive the  		palliative care offered by hospice.</p>
<p>This focus on palliative care also affects the definitions of  		appropriate use, access to care, and cost-effectiveness in hospice relative to  		other Medicare benefits. Physicians may be less likely to recommend this course  		of "treatment." Once on hospice, nurses and other providers must refocus their  		care from restoring patient health to making them more comfortable. Hence,  		unlike the overutilization concerns with the rest of the Medicare benefits,  		inappropriate use in hospice may refer to underutilization problems. Barriers  		to access are more likely because of the negative connotations associated with  		dying instead of curing. Physicians must discuss the patient's preferences to  		waive treatment and then certify that death is expected within six months of  		enrollment. And cost reduction is related to the difference in providing  		relatively passive, less expensive comfort care in place of intensive,  		sometimes desperate high cost treatments for terminally ill patients. While  		this report can not address the question of appropriate use, it can provide  		information on the types of beneficiaries who enroll in Medicare's hospice  		benefit, how they are using it, and how this may be related to other public  		policies.</p>
<h2><a name="section2" id="section2">DATA AND METHODS</a></h2>
<p>This study uses 1996 and 1997 Medicare claims for beneficiaries who  		enrolled in Medicare's hospice benefit in 1996 (sample = 349, 229 enrollees).  		Beneficiary-level files were constructed from inpatient, outpatient, skilled  		nursing facility, home health agency and hospice claims for each beneficiary as  		of January 1, 1996 and continuing through December 31, 1997. Payment and use  		estimates from physician and Part B claims, including DME, were not included in  		this study.<sup><font><a href="#note1">1</a></font></sup> Demographic  		and insurance variables for each hospice user were obtained from the July 1,  		1996 Medicare Denominator file. Files were merged by beneficiary health  		insurance master claim numbers. The final analytic files provide near complete  		Medicare claims information for 1996 and 1997 for the population having at  		least one hospice claim in 1996.<sup><font><a href="#note2">2</a></font></sup></p>
<h3>Sample</h3>
<p>The sample was restricted to beneficiaries whose first hospice benefit  		period began on or after January 1, 1996. Cases were excluded if the "from"  		date on the first claim preceded January 1, 1996, the benefit period on the  		first claim was greater than 1, the total Medicare payments equaled "0", or the  		hospice provider was outside the 50 states or the District of Columbia. This  		resulted in a study sample of 317,198 beneficiaries. Claims were edited to  		exclude duplicate claims. Beneficiary-level files were constructed for this  		cohort (1996 hospice enrollment) to measure total per person utilization by  		each type of service for the 2-year study period (1996 and 1997).</p>
<p>Complete information on hospice payments and use and Medicare payments  		and use in the 6 months preceding hospice enrollment are presented for the 1996  		hospice cohort. Medicare payments and use in the six months prior to each  		beneficiary's hospice enrollment is limited to beneficiaries whose first claim  		was on or after July 1, 1996 (n=146,572).</p>
<p>Hospice payment and use levels also are contrasted for two other  		subgroups of enrollees: those who had Medicaid buyin coverage at least once and  		those who were enrolled in an HMO at least once during the 12 month period  		preceding July 1, 1996. These variables were tested for statistically  		significant differences at the .01 level or less between both pairs of contrast  		groups. They are used as control measures in the multivariate analyses  		predicting total hospice payments and use.</p>
<h3>Variables</h3>
<p>This study presents information on hospice enrollees' demographic and  		insurance characteristics and their utilization and program payment levels.  		Included are beneficiary age in July 1996, and categorical measures of gender  		(Female/male), race (white/not white), Medicaid buyin coverage (yes/no), HMO  		enrollment (yes/no), and primary diagnosis. Most of the measures are  		straightforward; but three variables warrant extra discussion.</p>
<p>Primary diagnosis is based on the primary diagnosis on the first hospice  		claim in the first benefit period in 1996. This was based on a preliminary  		analysis of the changes in diagnosis across each individual's hospice claims.  		About 98.4 percent of all claims per person had the same diagnosis across  		claims. Each of the ten most frequent primary diagnosis are included as  		dichotomous variables (yes/no to having that primary diagnosis).</p>
<p>The other two variables warrant discussion because they measure the  		occurrence of an event at least once during the year the beneficiary was  		enrolled in hospice but may not have occurred during the hospice enrollment.  		These measures are indicators of a type of beneficiary rather than  		specification of insurance at the time of hospice use. The two measures include  		"HMO enrollment" and "Medicaid enrollment." The HMO enrollment measure is an  		indicator variable that is used as a description of the beneficiary and to  		exclude these cases from the denominator when calculating non-hospice Medicare  		use and payments. While it is important to exclude these enrollees from the  		denominator in claims-based analysis, HMO enrollment does not affect hospice  		payments and use because these claims are submitted regardless of whether the  		beneficiary is in an HMO.</p>
<p>The Medicaid indicator is based on the beneficiary being covered by a  		state Medicaid buyin policy at least once during the year. Because this  		population is at the end of life (by definition), we assume that once they  		qualify for Medicaid coverage they remain income-eligible and covered the rest  		of the year.</p>
<h2><a name="section3" id="section3">ANALYSIS</a></h2>
<p>The following sections describe the types of beneficiaries who use  		Medicare's hospice benefit, how they use it, the program payments associated  		with use, and changes in the types of beneficiaries who are using it.</p>
<h3>Who Uses Medicare's Hospice Benefit?</h3>
<p><b>Demographic Characteristics</b>. Hospice users tend to be older than  		the general Medicare population -- only five percent of the users in 1996 were  		younger than 65 compared to 12.2 percent of all beneficiaries (<a href="#table1">Table 1</a>). Almost 40 percent (38.6 percent) were between 75  		and 84 years old. And 26.6 percent were at least 85 years compared to only 10.3  		percent in the total Medicare population.</p>
<p>Hospice enrollees, even more than the general Medicare population, tend  		to be white (89.7 percent); a small proportion are black (7.3 percent). Males  		represent a disproportionately larger share of hospice enrollees than they do  		in the Medicare population at large (47.0 percent compared to 42.9 percent of  		all beneficiaries). This suggests they are more likely than women to enroll in  		hospice, relatively speaking, although less likely than in 1990, when they  		represented 53 percent of the hospice enrollees (Banaszak-Holl and Mor, 1995).  		</p>
<table title="TABLE 1. Characteristics of Medicare Hospice Users"><tr><td colspan="3"><font><b><a name="table1" id="table1">TABLE 1</a>. Characteristics of Medicare  			 Hospice Users</b></font></td>
</tr><tr><td scope="col"><font><b>  Characteristic  </b></font></td>
<td scope="col"><font><b>  Percent of  			 Users<sup>1</sup>  </b></font></td>
<td scope="col"><font><b>  Percent of All  			 Medicare<sup>2</sup>  </b></font></td>
</tr><tr><td colspan="3" scope="row"><font>Age</font></td>
</tr><tr><td scope="row"><font>   &lt;65</font></td>
<td><font>5.0%</font></td>
<td><font>12.2%</font></td>
</tr><tr><td scope="row"><font>   65-74</font></td>
<td><font>29.7</font></td>
<td><font>47.8</font></td>
</tr><tr><td scope="row"><font>   75-84</font></td>
<td><font>38.6</font></td>
<td><font>29.7</font></td>
</tr><tr><td scope="row"><font>   85 or older</font></td>
<td><font>26.6</font></td>
<td><font>10.3</font></td>
</tr><tr><td colspan="3" scope="row"><font>Race</font></td>
</tr><tr><td scope="row"><font>   White</font></td>
<td><font>89.7</font></td>
<td><font>85.4</font></td>
</tr><tr><td scope="row"><font>   Black</font></td>
<td><font>7.3</font></td>
<td><font>9.0</font></td>
</tr><tr><td scope="row"><font>   Other</font></td>
<td><font>3.0</font></td>
<td><font>5.6</font></td>
</tr><tr><td colspan="3" scope="row"><font>Sex</font></td>
</tr><tr><td scope="row"><font>   Female</font></td>
<td><font>53.0</font></td>
<td><font>57.1</font></td>
</tr><tr><td scope="row"><font>   Male</font></td>
<td><font>47.0</font></td>
<td><font>42.9</font></td>
</tr><tr><td scope="row"><font>Medicaid  			 Buyin</font></td>
<td><font>16.1</font></td>
<td><font>13.8<sup>3</sup></font></td>
</tr><tr><td scope="row"><font>Any HMO  			 Coverage  </font></td>
<td><font>14.9</font></td>
<td><font>11.0<sup>4</sup></font></td>
</tr><tr><td colspan="3" scope="row">
<ol><li><font>Analysis of Medicare Denominator file, July  				  1996</font></li>
<li><font>HCFR, 1998 Statistical Supplement</font></li>
<li><font>HCFA Data Compendium, 1998 for 1996</font></li>
<li><font>As of December 1996</font></li>
</ol></td>
</tr></table><p><b>Insurance Coverage</b>. Over 16 percent (16.1 percent) of the users  		have Medicaid coverage in addition to Medicare coverage. This is similar to the  		Medicare population at large which suggests the dually-eligible have equal  		access to hospice coverage relative to other beneficiaries. Similarly, 14.9  		percent of the hospice enrollees were enrolled in an HMO at some time during  		1996 compared to 11.3 percent of the total population. These numbers indicate  		that beneficiaries in both HMOs and state Medicaid programs have equal access  		to hospice services. It is unclear whether these differences in enrollment are  		significant enough to suggest these programs are enrolling disproportionately  		large numbers in Medicare's hospice benefit to restrict their respective costs  		for terminally ill enrollees.</p>
<p><b>Common diagnoses</b>. Cancer remains a dominant diagnosis in the  		hospice population. About 63 percent of all hospice enrollees have at least one  		type of cancer as their primary diagnosis; the total number having some type of  		cancer is even greater. Cancer accounts for 6 of the top 10 primary diagnoses  		in the hospice population (<a href="#table2">Table 2</a>). Lung cancer is the  		most common and represents 16.5 percent of all hospice cases in 1996, down from  		23 percent in 1990 (Banaszak-Holl and Mor, 1995). Congestive heart failure,  		chronic airway obstructions, acute cerebrovascular disease or stroke, and  		Alzheimer's Disease (AD) are the other most common diagnoses in this  		population. (These diagnoses also were among the top ten causes of death in the  		65 and older population in 1995 (Rosenberg et al., 1996).)</p>
<table title="TABLE 2. Top 10 Primary Diagnoses in Hospice"><tr><td colspan="2"><font><b>  <a name="table2" id="table2">TABLE 2</a>. Top 10 Primary  			 Diagnoses in Hospice  </b></font></td>
</tr><tr><td scope="col"><font><b>  Primary  			 Diagnosis  </b></font></td>
<td scope="col"><font><b>  Percent of  			 Users  </b></font></td>
</tr><tr><td scope="row"><font>Lung  			 Cancer</font></td>
<td><font>16.5%</font></td>
</tr><tr><td scope="row"><font>Congestive  			 Heart Failure</font></td>
<td><font>5.7</font></td>
</tr><tr><td scope="row"><font>Prostate  			 Cancer</font></td>
<td><font>5.3</font></td>
</tr><tr><td scope="row"><font>Breast  			 Cancer</font></td>
<td><font>4.0</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Airway Obstruction</font></td>
<td><font>4.0</font></td>
</tr><tr><td scope="row"><font>Colon  			 Cancer</font></td>
<td><font>3.4</font></td>
</tr><tr><td scope="row"><font>Pancreas  			 Cancer</font></td>
<td><font>3.2</font></td>
</tr><tr><td scope="row"><font>Acute  			 Cerebrovascular Disease (CVA)  </font></td>
<td><font>2.9</font></td>
</tr><tr><td scope="row"><font>Rectosigmoid  			 Cancer</font></td>
<td><font>2.3</font></td>
</tr><tr><td scope="row"><font>Alzheimer's  			 Disease</font></td>
<td><font>2.3</font></td>
</tr><tr><td colspan="2" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic file,  			 1996</font></td>
</tr></table><h3>Hospice Utilization Patterns</h3>
<p><b>Election Periods</b>. In 1996, Medicare beneficiaries were allowed to  		elect hospice four times. As mentioned in the literature review, this provision  		corrects for the difficulty in prognosticating death by allowing a beneficiary  		to disenroll from hospice if their health improves but re-enroll for palliative  		care at a later date. In 1996, the four periods were divided into two periods  		up to 90 days each, followed by a third period lasting up to 60 days, and a  		fourth period of unlimited duration. Use was restricted, however, to a total of  		four coverage periods and once a beneficiary disenrolled from one period they  		could no longer use the remaining days in that period. These benefit periods  		may have been used continuously or beneficiaries may have disenrolled and  		re-elected coverage at a later date. The BBA changed these coverage provisions  		to allow an unlimited number of benefit periods. However, beneficiaries must be  		recertified every 60 days following the first two 90 day periods. In effect,  		the benefit was expanded to provide two 90 day periods followed by an unlimited  		number of 60 day periods.</p>
<p>Most hospice enrollees (79.6 percent) only used one benefit period prior  		to death in 1996 (<a href="#table3">Table 3</a>). Another 11.6 percent used a  		second benefit period. Only 8.8 percent had more than two benefit periods.</p>
<table title="TABLE 3. Hospice Expenditures and Utilization by Number of Benefit Periods Utilized"><tr><td colspan="5"><font><b>  <a name="table3" id="table3">TABLE 3</a>. Hospice  			 Expenditures and Utilization by Number of Benefit Periods  			 Utilized  </b></font></td>
</tr><tr><td rowspan="2" scope="col"><font> </font></td>
<td colspan="4" scope="col"><font><font><b>Number of Benefit  			 Periods</b></font></font></td>
</tr><tr><td scope="col"><font><b>1</b></font></td>
<td scope="col"><font><b>2</b></font></td>
<td scope="col"><font><b>3</b></font></td>
<td scope="col"><font><b>4</b></font></td>
</tr><tr><td scope="row"><font>No. of Days  			 Allowed in 1996</font></td>
<td><font>90</font></td>
<td><font>90</font></td>
<td><font>60</font></td>
<td><font>Unlimited if continuous  			 hospice enrollment  </font></td>
</tr><tr><td scope="row"><font>Share of  			 Enrollees</font></td>
<td><font>79.6%</font></td>
<td><font>11.6%</font></td>
<td><font>2.4%</font></td>
<td><font>6.4%</font></td>
</tr><tr><td scope="row"><font>Enrolled Days  			 Per Period</font></td>
<td><font>  37  			 days  </font></td>
<td><font>  60  			 days  </font></td>
<td><font>  27  			 days  </font></td>
<td><font>148 days</font></td>
</tr><tr><td scope="row"><font>Average  			 Payments Per Period  </font></td>
<td><font>$4,029</font></td>
<td><font>$6,062</font></td>
<td><font>$2,685</font></td>
<td><font>$14,522</font></td>
</tr><tr><td colspan="5" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files,  			 1996</font></td>
</tr></table><p><b>Use Levels in Each Period</b>. Service use varies by benefit period  		being used. Enrollees in their fourth benefit period used 4 times more covered  		days per period than those in the first benefit period. This may be have been  		due to this being the beneficiaries' last opportunity for hospice coverage. As  		a result, they may have remained on it longer than needed in order to ensure  		they were covered just before death. In contrast, beneficiaries in their third  		period used only 73 percent as many days as those in the first period.</p>
<p>The new BBA rules may lead to fewer days per election period in the  		fourth period if the long length of stay in the fourth period was due to  		beneficiaries not wanting to lose the benefit. On the other hand, while the BBA  		increased access for beneficiaries, it also provides an incentive for  		beneficiaries to disenroll for curative treatments and re-elect hospice  		coverage at a later date. This may result in greater total Medicare program  		costs for chronic populations whose death is difficult to predict, such as  		patients with a primary diagnosis of AD. Whether this occurs will remain to be  		seen in the post-BBA utilization patterns.</p>
<p>The average Medicare payment per day is greatest in the first benefit  		period and steadily declines to the fourth benefit period ($108/day compared to  		$98/day). This suggests that beneficiaries are using different levels of  		hospice services across the periods, with the most expensive services occurring  		in the first benefit period. While this reflects the higher costs of those who  		only use one benefit period prior to death, the lower daily payment in the  		fourth period suggests these longer surviving enrollees are using less  		intensive services. This may reflect differences in the type of patient who  		survive to use four benefit periods compared to those who only use one period.  		</p>
<p><b>Variation by Diagnosis</b>. Use of the benefit varies by diagnosis  		(<a href="#table4">Table 4</a>). The three groups that were least likely to  		have more than one benefit period were beneficiaries with a primary diagnosis  		of lung cancer, pancreatic cancer, or cerebrovascular disease (CVA/stroke).  		About 82-84 percent of these beneficiaries used only one benefit period. In  		contrast, beneficiaries with more chronic conditions, like Alzheimer's Disease  		(AD) were most likely to use multiple enrollment periods. Over 13 percent of  		the hospice enrollees with a primary diagnosis of AD used 4 enrollment periods  		while another 18.9 percent had more than one enrollment period. (As will be  		seen later in <a href="#table7">Table 7</a>, AD patients also have less  		intensive service patterns than other cases.)</p>
<table title="TABLE 4. Share of Cases by Number of Hospice Benefit Periods Utilized or Those Ending in Death, by Primary Diagnosis"><tr><td colspan="6"><font><b>  <a name="table4" id="table4">TABLE 4</a>. Share of Cases by  			 Number of Hospice Benefit Periods Utilized or Those Ending in Death, by Primary  			 Diagnosis  </b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><font><b>Primary  			 Diagnosis</b></font> </font></td>
<td colspan="4" scope="col"><font><b>Share of Cases by  			 Number  of Hospice Benefit Periods  			 Used  </b></font></td>
<td rowspan="2" scope="col"><font><font><b>Share  			 of  Cases Ending  in Death</b></font> </font></td>
</tr><tr><td scope="col"><font><b>1</b></font></td>
<td scope="col"><font><b>2</b></font></td>
<td scope="col"><font><b>3</b></font></td>
<td scope="col"><font><b>4</b></font></td>
</tr><tr><td scope="row"><font>Lung  			 Cancer</font></td>
<td><font>  82.3%  </font></td>
<td><font>  11.2%  </font></td>
<td><font>  1.8%  </font></td>
<td><font>  4.7%  </font></td>
<td><font>98.9%</font></td>
</tr><tr><td scope="row"><font>Congestive  			 Heart Failure</font></td>
<td><font>77.1</font></td>
<td><font>12.0</font></td>
<td><font>2.9</font></td>
<td><font>7.9</font></td>
<td><font>95.0</font></td>
</tr><tr><td scope="row"><font>Prostate  			 Cancer</font></td>
<td><font>75.4</font></td>
<td><font>14.5</font></td>
<td><font>2.9</font></td>
<td><font>7.2</font></td>
<td><font>98.0</font></td>
</tr><tr><td scope="row"><font>Breast  			 Cancer</font></td>
<td><font>75.2</font></td>
<td><font>13.1</font></td>
<td><font>2.6</font></td>
<td><font>9.0</font></td>
<td><font>96.8</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Airway Obstruction</font></td>
<td><font>70.8</font></td>
<td><font>13.7</font></td>
<td><font>3.9</font></td>
<td><font>11.7</font></td>
<td><font>93.9</font></td>
</tr><tr><td scope="row"><font>Colon  			 Cancer</font></td>
<td><font>79.7</font></td>
<td><font>12.2</font></td>
<td><font>2.2</font></td>
<td><font>5.9</font></td>
<td><font>98.6</font></td>
</tr><tr><td scope="row"><font>Pancreas  			 Cancer</font></td>
<td><font>83.9</font></td>
<td><font>10.6</font></td>
<td><font>1.6</font></td>
<td><font>3.8</font></td>
<td><font>98.7</font></td>
</tr><tr><td scope="row"><font>Acute  			 Cerebrovascular Disease (CVA)  </font></td>
<td><font>83.9</font></td>
<td><font>8.5</font></td>
<td><font>2.2</font></td>
<td><font>5.4</font></td>
<td><font>95.0</font></td>
</tr><tr><td scope="row"><font>Rectosigmoid  			 Cancer</font></td>
<td><font>79.6</font></td>
<td><font>12.4</font></td>
<td><font>2.4</font></td>
<td><font>5.5</font></td>
<td><font>98.5</font></td>
</tr><tr><td scope="row"><font>Alzheimer's  			 Disease</font></td>
<td><font>68.0</font></td>
<td><font>14.5</font></td>
<td><font>4.4</font></td>
<td><font>13.1</font></td>
<td><font>89.3</font></td>
</tr><tr><td colspan="6" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic Files, 1996 and  			 1997</font></td>
</tr></table><p><b>Death as Outcome</b>. Almost all beneficiaries died at the end of  		their hospice enrollment (96.7 percent). This is particularly true for cancer  		patients--at least 98 percent of these patients' hospice care ended in death.  		This, coupled with the greater use of just one benefit period, suggests cancer  		cases are receiving hospice services at the very end of their terminal illness.  		This may be reflecting the physician's greater ability to predict end of life  		with this population. Beneficiaries with AD, on the other hand, were the least  		likely of those having one of the top 10 primary diagnosis, to die at the end  		of their hospice enrollment -- only 89.3 percent. Still, most of these  		patients' cases end with death at the end of enrollment. This suggests hospice  		is not being used to simply supplement home health care for this chronic  		population but that the benefit is being used at the end of life as intended.  		The relatively lower death rates for the non-cancer cases support the  		contention that death is more difficult to predict for these cases (Fox et al,  		1999b).</p>
<h3>Hospice Expenditures</h3>
<p>Medicare's hospice expenditures have grown dramatically since the  		benefit's inception in 1983. In 1996, 2 billion dollars were spent on hospice,  		up from 8 million dollars in 1984. The average payment per user in 1996 was  		$6,433 (<a href="#table5">Table 5</a>). However, like most Medicare  		expenditures, these figures are skewed by the small number of users with very  		high costs. The median payment per user was much lower -- half the hospice  		enrollees averaged Medicare hospice payments of $2,809 per user. Per diem  		payments also were skewed -- $135 per day while the median was only $99 per  		day.</p>
<table title="TABLE 5. Medicare Hospice Expenditures and Utilization"><tr><td colspan="3"><font><b>  <a name="table5" id="table5">TABLE 5</a>. Medicare Hospice  			 Expenditures and Utilization  </b></font></td>
</tr><tr><td scope="col"><font>  </font></td>
<td scope="col"><font><font><b>Mean</b></font> </font></td>
<td scope="col"><font><font><b>Median</b></font> </font></td>
</tr><tr><td colspan="3" scope="row"><font>Hospice Expenditures</font></td>
</tr><tr><td scope="row"><font>   Per Case</font></td>
<td><font>$6,433</font></td>
<td><font>$2,809</font></td>
</tr><tr><td scope="row"><font>   Per Day</font></td>
<td><font>$135</font></td>
<td><font>$99</font></td>
</tr><tr><td scope="row"><font>Number of  			 Days Enrolled  </font></td>
<td><font>  65  			 days  </font></td>
<td><font>  24  			 days  </font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, 1996 and  			 1997</font></td>
</tr></table><p><b>Variation by Use</b>. These payment differences reflect variations in  		length of enrollment and type of hospice service used. On average,  		beneficiaries remained on hospice for 65 days. However, half of the enrollees  		only enrolled for 24 days. In other words, most beneficiaries elected hospice  		for less than one month. This use level has declined slightly since 1990 when  		the mean and median were 67 and 25 days, respectively (Banaszak-Holl and Mor,  		1995). In 1996, only nine percent remained on hospice longer than the six  		months used to define eligibility.</p>
<p>Payments also vary by the type of service or level of coverage used (<a href="#table6">Table 6</a>). Medicare reimburses the hospice on a per diem  		basis. Five levels of payment are used reflecting physician services and the  		four different levels of care -- routine home care, which is the default level  		if no higher level of care is used per day; general inpatient care, which  		provides inpatient per diem coverage in a hospital, skilled nursing facility,  		or free-standing hospice; respite inpatient care, which is available for up to  		5 days per admission; and continuous home care, which provides crisis coverage  		at home for at least 8 hours a day. Per diem payments increase with the  		intensity of the services provided and they range from $97 a day for routine  		home care to a cap of $566 a day for continuous 24 hour coverage.</p>
<table title="TABLE 6. Hospice Use Levels by Type of Hospice Service"><tr><td colspan="4"><font><b><a name="table6" id="table6">TABLE 6</a>. Hospice Use Levels by Type of  			 Hospice Service</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><b>Type of Hospice  			 Service</b></font></td>
<td rowspan="2" scope="col"><font><font><b>  Share of  			 Enrollees with  at Least 1 Use</b></font> </font></td>
<td colspan="2" scope="col"><font><font><b>Level of Use Per  			 User</b></font> </font></td>
</tr><tr><td scope="col"><font><b>  Mean  </b></font></td>
<td scope="col"><font><b>  Median  </b></font></td>
</tr><tr><td scope="row"><font>Routine Home  			 Care Days</font></td>
<td><font>92%</font></td>
<td><font>64</font></td>
<td><font>26</font></td>
</tr><tr><td scope="row"><font>General  			 Inpatient Days</font></td>
<td><font>20</font></td>
<td><font>8</font></td>
<td><font>5</font></td>
</tr><tr><td scope="row"><font>Respite  			 Inpatient Days</font></td>
<td><font>3</font></td>
<td><font>5</font></td>
<td><font>5</font></td>
</tr><tr><td scope="row"><font>Continuous  			 Home Care Hours  </font></td>
<td><font>5</font></td>
<td><font>78</font></td>
<td><font>38</font></td>
</tr><tr><td scope="row"><font>Attending  			 Physician Visits*</font></td>
<td><font>13</font></td>
<td><font>5</font></td>
<td><font>2</font></td>
</tr><tr><td colspan="4"><font><b>SOURCE</b>: Analysis of Medicare  			 Standard Analytic files, 1996 and 1997* Physician services billed by  			 hospice. Excludes Part B bills.</font></td>
</tr></table><p>Given these program rules, routine home care is the most widely used  		level of coverage. Most beneficiaries (92 percent) had at least one routine  		home care day. On average, enrollees used 64 days of routine home care although  		this number also reflects a small number of users' very high use levels. The  		median number of routine home care days used was 26 days per person. It is  		interesting to note that not all hospice enrollees had a home care day. This  		suggests some beneficiaries elected hospice directly from the inpatient setting  		or to receive continuous home care before dying.<sup><font><a href="#note3">3</a></font></sup> This supports the concern that beneficiaries  		are not receiving the full potential of the benefit available to them and may  		be enrolling in hospice at the "last minute."</p>
<p>About 20 percent of the hospice enrollees had at least one day in a  		general inpatient setting. Average use levels included 8 days in an inpatient  		setting although the median use level for this type of care was 5 days. While  		hospices are not allowed to provide more than 20 percent of their patient days  		in an inpatient setting, this percentage applies to the provider on an annual  		basis, not an individual beneficiary. As with the home care days, mean  		utilization levels were skewed by a small number of users with very long use  		periods. This is true for all hospice counts except respite inpatient days. For  		the three percent of enrollees who used respite inpatient care, almost all used  		the five days allowed under the benefit. This may reflect scheduling patterns  		since respite services are scheduled for a set period rather than admissions  		that occur in response to changes in a patient's condition.</p>
<p>Beneficiaries are allowed to keep their attending physician or they may  		switch to a hospice physician once they enroll in the benefit. Only 13 percent  		of the hospice enrollees had a claim for a hospice physician's visit. While  		this number only reflects billed time for direct care and excludes the hospice  		physician's oversight, or administrative responsibilities for overseeing each  		enrollee's treatment, it suggests most beneficiaries keep their attending  		physician rather than switching to hospice physicians to manage their hospice  		care.</p>
<p><b>Variation by Diagnosis</b>. Medicare payments and patterns of use  		also vary by the enrollee's medical condition (<a href="#table7">Table 7</a>).  		The most expensive hospice enrollee is the beneficiary who has Alzheimer's  		disease. Their average payment per case is $9,824 or $128 per day. The  		relatively low payment per day suggests that the high costs are due to higher  		utilization levels not use of more expensive levels of care. In fact, the mean  		length of stay on hospice for a beneficiary with Alzheimer's disease is 104  		days, of which 101 days, on average, are routine home care days. Even the  		median level of enrolled days (34 days) for this population is 42 percent  		greater than for the average hospice user. Use levels for AD cases are higher  		than average for each type of hospice service as well, except physician visits  		which are lower than average -- 4.3 visits versus 4.5 visits per user. Patients  		with AD use 57 percent more routine home care than the average user -- 100.7  		days compared to only 64.0 days.</p>
<p>CVA or stroke cases, in contrast, average only $5,539 per case but have  		high average daily payments -- $177 per day. These cases have shorter lengths  		of stay -- 54 days on average or a median length of 10 days per case -- but a  		slightly higher use of more expensive inpatient days, both general and respite  		inpatient services. In addition, a greater proportion of stroke cases use  		inpatient care (26 percent of all cases compared to only 20 percent on  		average). This group also has the fewest number of patients using routine home  		care -- only 79 percent had at least one day of routine home care. These cases  		appear to be enrolling in hospice just prior to death. This may be a reflection  		of the shorter length of time between onset of a stroke and death.</p>
<p>Cancer cases, on the other hand, have a much more predictable course of  		illness, although treatment patterns and costs vary among the different types  		of cancer. The late stage cancer patient is more easily identified and is using  		a greater mix of hospice services. Patients with breast cancer are among the  		most costly of the most frequently occurring cancer cases. The average payment  		per case is $7,695, much of which can be explained by a long coverage period --  		an average of 77 days per case. These users have high average use levels for  		all four hospice levels of care except continuous home care. They average 9.6  		days per case in the general inpatient setting and use the 5 days inpatient  		respite care. Patients with lung cancer, on the other hand, enroll in the  		hospice benefit for much shorter periods -- 56 days on average or 25 days for  		the median -- and also have relatively inexpensive hospice treatments -- $125  		per day or 28 percent lower than the average hospice patient.</p>
<p><b>Variation by State</b>. As with other Medicare benefits, hospice  		payments and use also vary by geographic area (<a href="#table8">Table 8</a>).  		The five states with the largest number of hospice enrollees also have large  		numbers of elderly (Florida, California, Texas, Ohio, and New York). After  		adjusting for differences in the number of beneficiaries in each state, the  		four states with the largest proportional enrollments in hospice also are among  		the states with the highest proportion of beneficiaries enrolled in HMOs  		(Arizona, Colorado, and Florida) or as in the case of Oregon are known for  		encouraging alternative end of life options.<sup><font><a href="#note4">4</a></font></sup> The average number of hospice enrollees in  		these high use states ranges from 11 per 1000 beneficiaries up to 15 per 1000  		in Arizona. States with the lowest proportion of hospice enrollees include  		Alaska, Maine, and Utah, which have fewer than 4 enrollees per 1000  		beneficiaries.</p>
<p>The average payment per day in the three states with high hospice  		enrollment is relatively high, ranging from $187 per day in Arizona to $149 per  		day in Colorado. Arizona is only exceeded by Connecticut, which has the highest  		payment per day ($228 per day), but very low use rates -- 44 days in hospice  		compared to 65, on average. Connecticut's high daily costs are related to its  		extraordinarily high use of general inpatient hospice services -- 12 days  		compared to the overall average of 7.7 days. These high inpatient days are  		exceeded only by enrollees in Mississippi who use an average of 20.7 days in  		general inpatient care. These high inpatient days are offset by a higher than  		average number of home care days, keeping the average payment per day  		relatively low in Mississippi ($109 per day) but resulting in the third highest  		payments per case in the nation.</p>
<table title="TABLE 7. Mean Hospice Expenditures and Utilization by Primary Diagnosis"><tr><td colspan="10"><font><b><a name="table7" id="table7">TABLE 7</a>. Mean (and Median) Hospice  			 Expenditures and Utilization by Primary Diagnosis</b></font></td>
</tr><tr><td scope="col"><font> </font></td>
<td scope="col"><font><b>Hospice/  Payment  Case</b></font></td>
<td scope="col"><font><b>Hospice/  Payment  Day</b></font></td>
<td scope="col"><font><b>  Enrolled  Days</b></font></td>
<td scope="col"><font><b>  Covered  Days</b></font></td>
<td scope="col"><font><b>  Physician  Visits</b></font></td>
<td scope="col"><font><b>Routine  Home  			 Care  Days</b></font></td>
<td scope="col"><font><b>Respite  Inpatient  Days</b></font></td>
<td scope="col"><font><b>General  Inpatient  Days</b></font></td>
<td scope="col"><font><b>  Continuous  Home  			 CareHours</b></font></td>
</tr><tr><td rowspan="2" scope="row"><font>All</font></td>
<td><font>$6,433</font></td>
<td><font>$135</font></td>
<td><font>65</font></td>
<td><font>61</font></td>
<td><font>4.5</font></td>
<td><font>64.0</font></td>
<td><font>5.0</font></td>
<td><font>7.0</font></td>
<td><font>78.0</font></td>
</tr><tr><td><font>(2,809)</font></td>
<td><font>(99)</font></td>
<td><font>(24)</font></td>
<td><font>(24)</font></td>
<td><font>(2)</font></td>
<td><font>(26)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(38)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Lung Cancer</font></td>
<td><font>5,619</font></td>
<td><font>125</font></td>
<td><font>56</font></td>
<td><font>54</font></td>
<td><font>4.6</font></td>
<td><font>54.0</font></td>
<td><font>4.5</font></td>
<td><font>7.4</font></td>
<td><font>72.0</font></td>
</tr><tr><td><font>(2,639)</font></td>
<td><font>(98)</font></td>
<td><font>(25)</font></td>
<td><font>(25)</font></td>
<td><font>(2)</font></td>
<td><font>(25)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(36)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Congestive Heart Failure</font></td>
<td><font>7,018</font></td>
<td><font>136</font></td>
<td><font>73</font></td>
<td><font>68</font></td>
<td><font>4.3</font></td>
<td><font>73.0</font></td>
<td><font>5.3</font></td>
<td><font>7.2</font></td>
<td><font>67.0</font></td>
</tr><tr><td><font>(2,639)</font></td>
<td><font>(98)</font></td>
<td><font>(22)</font></td>
<td><font>(22)</font></td>
<td><font>(2)</font></td>
<td><font>(26)</font></td>
<td><font>(5)</font></td>
<td><font>(4)</font></td>
<td><font>(36)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Prostate Cancer</font></td>
<td><font>7,125</font></td>
<td><font>124</font></td>
<td><font>73</font></td>
<td><font>68</font></td>
<td><font>4.9</font></td>
<td><font>69.0</font></td>
<td><font>4.9</font></td>
<td><font>8.2</font></td>
<td><font>72.0</font></td>
</tr><tr><td><font>(3,648)</font></td>
<td><font>(98)</font></td>
<td><font>(33)</font></td>
<td><font>(33)</font></td>
<td><font>(2)</font></td>
<td><font>(34)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(37)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Breast Cancer</font></td>
<td><font>7,695</font></td>
<td><font>128</font></td>
<td><font>77</font></td>
<td><font>73</font></td>
<td><font>5.6</font></td>
<td><font>74.0</font></td>
<td><font>5.0</font></td>
<td><font>9.6</font></td>
<td><font>71.4</font></td>
</tr><tr><td><font>(3,524)</font></td>
<td><font>(99)</font></td>
<td><font>(31)</font></td>
<td><font>(31)</font></td>
<td><font>(2)</font></td>
<td><font>(32)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(41)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Chronic Airway Obstruction</font></td>
<td><font>8,858</font></td>
<td><font>135</font></td>
<td><font>92</font></td>
<td><font>86</font></td>
<td><font>4.8</font></td>
<td><font>90.9</font></td>
<td><font>5.4</font></td>
<td><font>7.8</font></td>
<td><font>79.1</font></td>
</tr><tr><td><font>(3,592)</font></td>
<td><font>(99)</font></td>
<td><font>(31)</font></td>
<td><font>(30)</font></td>
<td><font>(2)</font></td>
<td><font>(36)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(34)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Colon Cancer</font></td>
<td><font>6,407</font></td>
<td><font>130</font></td>
<td><font>63</font></td>
<td><font>60</font></td>
<td><font>4.9</font></td>
<td><font>61.0</font></td>
<td><font>4.8</font></td>
<td><font>8.0</font></td>
<td><font>71.5</font></td>
</tr><tr><td><font>(3,261)</font></td>
<td><font>(99)</font></td>
<td><font>(29)</font></td>
<td><font>(29)</font></td>
<td><font>(2)</font></td>
<td><font>(30)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(39)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Pancreas Cancer</font></td>
<td><font>5,355</font></td>
<td><font>129</font></td>
<td><font>52</font></td>
<td><font>50</font></td>
<td><font>4.4</font></td>
<td><font>50.4</font></td>
<td><font>4.3</font></td>
<td><font>7.6</font></td>
<td><font>72.0</font></td>
</tr><tr><td><font>(2,771)</font></td>
<td><font>(99)</font></td>
<td><font>(25)</font></td>
<td><font>(24)</font></td>
<td><font>(2)</font></td>
<td><font>(25)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(35)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Acute Cerebrovascular Disease (CVA)  </font></td>
<td><font>5,539</font></td>
<td><font>177</font></td>
<td><font>54</font></td>
<td><font>50</font></td>
<td><font>4.4</font></td>
<td><font>60.3</font></td>
<td><font>5.8</font></td>
<td><font>7.3</font></td>
<td><font>66.4</font></td>
</tr><tr><td><font>(1,763)</font></td>
<td><font>(102)</font></td>
<td><font>(10)</font></td>
<td><font>(10)</font></td>
<td><font>(2)</font></td>
<td><font>(14)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(43)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Rectosigmoid Cancer</font></td>
<td><font>6,274</font></td>
<td><font>233</font></td>
<td><font>63</font></td>
<td><font>60</font></td>
<td><font>4.7</font></td>
<td><font>60.0</font></td>
<td><font>5.2</font></td>
<td><font>9.1</font></td>
<td><font>73.5</font></td>
</tr><tr><td><font>(3,368)</font></td>
<td><font>(98)</font></td>
<td><font>(31)</font></td>
<td><font>(30)</font></td>
<td><font>(2)</font></td>
<td><font>(31)</font></td>
<td><font>(5)</font></td>
<td><font>(6)</font></td>
<td><font>(41)</font></td>
</tr><tr><td rowspan="2" scope="row"><font>Alzheimer's Disease</font></td>
<td><font>9,824</font></td>
<td><font>128</font></td>
<td><font>104</font></td>
<td><font>96</font></td>
<td><font>4.3</font></td>
<td><font>100.7</font></td>
<td><font>6.6</font></td>
<td><font>8.2</font></td>
<td><font>83.3</font></td>
</tr><tr><td><font>(3,965)</font></td>
<td><font>(99)</font></td>
<td><font>(34)</font></td>
<td><font>(33)</font></td>
<td><font>(2)</font></td>
<td><font>(41)</font></td>
<td><font>(5)</font></td>
<td><font>(5)</font></td>
<td><font>(43)</font></td>
</tr><tr><td colspan="10" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, 1996 and  			 1997</font></td>
</tr></table><table title="TABLE 8. Geographic Variation in Hospice Expenditures and Utilization"><tr><td colspan="11"><font><b><a name="table8" id="table8">TABLE 8</a>. Geographic Variation in  			 Hospice Expenditures and Utilization</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font> </font></td>
<td colspan="2" scope="col"><font><b>Hospice  			 Enrollees</b></font></td>
<td rowspan="2" scope="col"><font><b>Hospice  Payment/  Case</b></font></td>
<td rowspan="2" scope="col"><font><b>Hospice  Payment/  Day</b></font></td>
<td rowspan="2" scope="col"><font><b>  Enrolled  Days</b></font></td>
<td rowspan="2" scope="col"><font><b>  Physician  Visits</b></font></td>
<td rowspan="2" scope="col"><font><b>Routine  Home  			 Care  Days</b></font></td>
<td rowspan="2" scope="col"><font><b>Respite  Inpatient  Days</b></font></td>
<td rowspan="2" scope="col"><font><b>General  Inpatient  Days</b></font></td>
<td rowspan="2" scope="col"><font><b>  Continuous  Home  			 CareHours</b></font></td>
</tr><tr><td scope="col"><font><b>  Total  </b></font></td>
<td scope="col"><font><b>  Per 1000  </b></font></td>
</tr><tr><td scope="row"><font>United  			 States</font></td>
<td><font>317,198</font></td>
<td><font>8.50</font></td>
<td><font>$6,433</font></td>
<td><font>$134</font></td>
<td><font>65</font></td>
<td><font>4.5</font></td>
<td><font>64</font></td>
<td><font>4.9</font></td>
<td><font>7.7</font></td>
<td><font>78</font></td>
</tr><tr><td scope="row"><font>Alabama</font></td>
<td><font>5,409</font></td>
<td><font>8.28</font></td>
<td><font>7,012</font></td>
<td><font>106</font></td>
<td><font>76</font></td>
<td><font>5.1</font></td>
<td><font>72</font></td>
<td><font>4.8</font></td>
<td><font>11.5</font></td>
<td><font>92</font></td>
</tr><tr><td scope="row"><font>Alaska</font></td>
<td><font>123</font></td>
<td><font>3.46</font></td>
<td><font>7,289</font></td>
<td><font>128</font></td>
<td><font>62</font></td>
<td><font>2.5</font></td>
<td><font>62</font></td>
<td><font>4.3</font></td>
<td><font>6.3</font></td>
<td><font>17.3</font></td>
</tr><tr><td scope="row"><font>Arizona</font></td>
<td><font>9,304</font></td>
<td><font>15.09</font></td>
<td><font>7,476</font></td>
<td><font>187</font></td>
<td><font>68</font></td>
<td><font>6.1</font></td>
<td><font>71</font></td>
<td><font>5.1</font></td>
<td><font>9.1</font></td>
<td><font>58</font></td>
</tr><tr><td scope="row"><font>Arkansas</font></td>
<td><font>3,256</font></td>
<td><font>7.63</font></td>
<td><font>8,023</font></td>
<td><font>106</font></td>
<td><font>90</font></td>
<td><font>2.1</font></td>
<td><font>87</font></td>
<td><font>4.6</font></td>
<td><font>6.5</font></td>
<td><font>83</font></td>
</tr><tr><td scope="row"><font>California</font></td>
<td><font>32,479</font></td>
<td><font>8.72</font></td>
<td><font>6,770</font></td>
<td><font>137</font></td>
<td><font>62</font></td>
<td><font>2.7</font></td>
<td><font>60</font></td>
<td><font>5</font></td>
<td><font>7.3</font></td>
<td><font>190</font></td>
</tr><tr><td scope="row"><font>Colorado</font></td>
<td><font>5,310</font></td>
<td><font>12.20</font></td>
<td><font>5,310</font></td>
<td><font>149</font></td>
<td><font>52</font></td>
<td><font>4.5</font></td>
<td><font>51</font></td>
<td><font>4.5</font></td>
<td><font>5.7</font></td>
<td><font>41</font></td>
</tr><tr><td scope="row"><font>Connecticut</font></td>
<td><font>3,162</font></td>
<td><font>6.24</font></td>
<td><font>6,109</font></td>
<td><font>228</font></td>
<td><font>44</font></td>
<td><font>11.3</font></td>
<td><font>51</font></td>
<td><font>4.2</font></td>
<td><font>12</font></td>
<td><font>53</font></td>
</tr><tr><td scope="row"><font>Delaware</font></td>
<td><font>1,044</font></td>
<td><font>9.84</font></td>
<td><font>6,173</font></td>
<td><font>100</font></td>
<td><font>68</font></td>
<td><font>2.7</font></td>
<td><font>63</font></td>
<td><font>4</font></td>
<td><font>8.3</font></td>
<td><font>51</font></td>
</tr><tr><td scope="row"><font>Washington,  			 D.C.  </font></td>
<td><font>463</font></td>
<td><font>5.95</font></td>
<td><font>5,691</font></td>
<td><font>173</font></td>
<td><font>52</font></td>
<td><font>4.9</font></td>
<td><font>56</font></td>
<td><font>5.5</font></td>
<td><font>6.2</font></td>
<td><font>47</font></td>
</tr><tr><td scope="row"><font>Florida</font></td>
<td><font>34,505</font></td>
<td><font>12.81</font></td>
<td><font>6,844</font></td>
<td><font>171</font></td>
<td><font>65</font></td>
<td><font>5.3</font></td>
<td><font>69</font></td>
<td><font>4.8</font></td>
<td><font>7.4</font></td>
<td><font>96</font></td>
</tr><tr><td scope="row"><font>Georgia</font></td>
<td><font>6,956</font></td>
<td><font>8.09</font></td>
<td><font>5,952</font></td>
<td><font>111</font></td>
<td><font>66</font></td>
<td><font>5.7</font></td>
<td><font>64</font></td>
<td><font>5.2</font></td>
<td><font>7.4</font></td>
<td><font>164</font></td>
</tr><tr><td scope="row"><font>Hawaii</font></td>
<td><font>901</font></td>
<td><font>5.84</font></td>
<td><font>5,331</font></td>
<td><font>128</font></td>
<td><font>51</font></td>
<td><font>4.9</font></td>
<td><font>49</font></td>
<td><font>6.1</font></td>
<td><font>6.9</font></td>
<td><font>8</font></td>
</tr><tr><td scope="row"><font>Idaho</font></td>
<td><font>1,252</font></td>
<td><font>8.10</font></td>
<td><font>6,146</font></td>
<td><font>100</font></td>
<td><font>69</font></td>
<td><font>2.5</font></td>
<td><font>65</font></td>
<td><font>4.7</font></td>
<td><font>5.7</font></td>
<td><font>73</font></td>
</tr><tr><td scope="row"><font>Illinois</font></td>
<td><font>15,287</font></td>
<td><font>9.40</font></td>
<td><font>6,403</font></td>
<td><font>140</font></td>
<td><font>62</font></td>
<td><font>3.7</font></td>
<td><font>62</font></td>
<td><font>4.6</font></td>
<td><font>6.4</font></td>
<td><font>39</font></td>
</tr><tr><td scope="row"><font>Indiana</font></td>
<td><font>4,693</font></td>
<td><font>5.70</font></td>
<td><font>6,293</font></td>
<td><font>117</font></td>
<td><font>68</font></td>
<td><font>3.6</font></td>
<td><font>67</font></td>
<td><font>5.3</font></td>
<td><font>6.8</font></td>
<td><font>32</font></td>
</tr><tr><td scope="row"><font>Iowa</font></td>
<td><font>3,974</font></td>
<td><font>8.38</font></td>
<td><font>6,164</font></td>
<td><font>123</font></td>
<td><font>68</font></td>
<td><font>4.9</font></td>
<td><font>65</font></td>
<td><font>4.5</font></td>
<td><font>7.3</font></td>
<td><font>51</font></td>
</tr><tr><td scope="row"><font>Kansas</font></td>
<td><font>3,253</font></td>
<td><font>8.45</font></td>
<td><font>6,130</font></td>
<td><font>99</font></td>
<td><font>68</font></td>
<td><font>4.4</font></td>
<td><font>63</font></td>
<td><font>4.5</font></td>
<td><font>6.7</font></td>
<td><font>32</font></td>
</tr><tr><td scope="row"><font>Kentucky</font></td>
<td><font>5,520</font></td>
<td><font>9.24</font></td>
<td><font>7,146</font></td>
<td><font>113</font></td>
<td><font>80</font></td>
<td><font>6.6</font></td>
<td><font>76</font></td>
<td><font>4.6</font></td>
<td><font>6.9</font></td>
<td><font>59</font></td>
</tr><tr><td scope="row"><font>Louisiana</font></td>
<td><font>3,212</font></td>
<td><font>5.48</font></td>
<td><font>5,614</font></td>
<td><font>100</font></td>
<td><font>61</font></td>
<td><font>2.7</font></td>
<td><font>58</font></td>
<td><font>3.9</font></td>
<td><font>5.7</font></td>
<td><font>141</font></td>
</tr><tr><td scope="row"><font>Maine</font></td>
<td><font>720</font></td>
<td><font>3.50</font></td>
<td><font>6,679</font></td>
<td><font>99</font></td>
<td><font>75</font></td>
<td><font>4.9</font></td>
<td><font>74</font></td>
<td><font>5.2</font></td>
<td><font>6.8</font></td>
<td><font>47</font></td>
</tr><tr><td scope="row"><font>Maryland</font></td>
<td><font>4,737</font></td>
<td><font>7.70</font></td>
<td><font>5,641</font></td>
<td><font>116</font></td>
<td><font>58</font></td>
<td><font>4.1</font></td>
<td><font>55</font></td>
<td><font>4.9</font></td>
<td><font>7.3</font></td>
<td><font>104</font></td>
</tr><tr><td scope="row"><font>Massachusetts</font></td>
<td><font>6,751</font></td>
<td><font>7.14</font></td>
<td><font>5,239</font></td>
<td><font>120</font></td>
<td><font>54</font></td>
<td><font>3.8</font></td>
<td><font>51</font></td>
<td><font>5.1</font></td>
<td><font>10.2</font></td>
<td><font>40</font></td>
</tr><tr><td scope="row"><font>Michigan</font></td>
<td><font>14,551</font></td>
<td><font>10.71</font></td>
<td><font>6,183</font></td>
<td><font>144</font></td>
<td><font>61</font></td>
<td><font>3.8</font></td>
<td><font>61</font></td>
<td><font>5.2</font></td>
<td><font>7.5</font></td>
<td><font>47</font></td>
</tr><tr><td scope="row"><font>Minnesota</font></td>
<td><font>5,152</font></td>
<td><font>8.10</font></td>
<td><font>5,684</font></td>
<td><font>125</font></td>
<td><font>64</font></td>
<td><font>3.7</font></td>
<td><font>60</font></td>
<td><font>4.4</font></td>
<td><font>5.8</font></td>
<td><font>68</font></td>
</tr><tr><td scope="row"><font>Mississippi</font></td>
<td><font>2,240</font></td>
<td><font>5.55</font></td>
<td><font>7,846</font></td>
<td><font>109</font></td>
<td><font>82</font></td>
<td><font>3.7</font></td>
<td><font>77</font></td>
<td><font>5.1</font></td>
<td><font>20.7</font></td>
<td><font>199</font></td>
</tr><tr><td scope="row"><font>Missouri</font></td>
<td><font>7,301</font></td>
<td><font>8.72</font></td>
<td><font>6,518</font></td>
<td><font>95</font></td>
<td><font>74</font></td>
<td><font>3.6</font></td>
<td><font>70</font></td>
<td><font>4.8</font></td>
<td><font>5.8</font></td>
<td><font>25</font></td>
</tr><tr><td scope="row"><font>Montana</font></td>
<td><font>782</font></td>
<td><font>5.95</font></td>
<td><font>6,205</font></td>
<td><font>99</font></td>
<td><font>71</font></td>
<td><font>3.8</font></td>
<td><font>67</font></td>
<td><font>5.2</font></td>
<td><font>4.8</font></td>
<td><font>35</font></td>
</tr><tr><td scope="row"><font>Nebraska</font></td>
<td><font>1,705</font></td>
<td><font>6.8</font></td>
<td><font>5,439</font></td>
<td><font>94</font></td>
<td><font>65</font></td>
<td><font>3.9</font></td>
<td><font>61.9</font></td>
<td><font>4.8</font></td>
<td><font>6.3</font></td>
<td><font>32</font></td>
</tr><tr><td scope="row"><font>Nevada</font></td>
<td><font>1,673</font></td>
<td><font>7.99</font></td>
<td><font>6,737</font></td>
<td><font>170</font></td>
<td><font>59</font></td>
<td><font>4.4</font></td>
<td><font>59.4</font></td>
<td><font>5.2</font></td>
<td><font>7.1</font></td>
<td><font>38</font></td>
</tr><tr><td scope="row"><font>New  			 Hampshire</font></td>
<td><font>1,002</font></td>
<td><font>6.33</font></td>
<td><font>5,220</font></td>
<td><font>102</font></td>
<td><font>59</font></td>
<td><font>2.7</font></td>
<td><font>55</font></td>
<td><font>3.9</font></td>
<td><font>6</font></td>
<td><font>50</font></td>
</tr><tr><td scope="row"><font>New  			 Jersey</font></td>
<td><font>8,553</font></td>
<td><font>7.24</font></td>
<td><font>5,531</font></td>
<td><font>113</font></td>
<td><font>58</font></td>
<td><font>4.9</font></td>
<td><font>54</font></td>
<td><font>4.7</font></td>
<td><font>8.1</font></td>
<td><font>69</font></td>
</tr><tr><td scope="row"><font>New  			 Mexico</font></td>
<td><font>2,044</font></td>
<td><font>9.43</font></td>
<td><font>6,173</font></td>
<td><font>136</font></td>
<td><font>65</font></td>
<td><font>4.5</font></td>
<td><font>65</font></td>
<td><font>4.9</font></td>
<td><font>7.5</font></td>
<td><font>42</font></td>
</tr><tr><td scope="row"><font>New  			 York</font></td>
<td><font>17,127</font></td>
<td><font>6.49</font></td>
<td><font>6,465</font></td>
<td><font>153</font></td>
<td><font>58</font></td>
<td><font>4.4</font></td>
<td><font>57</font></td>
<td><font>4.7</font></td>
<td><font>9.8</font></td>
<td><font>72</font></td>
</tr><tr><td scope="row"><font>North  			 Carolina</font></td>
<td><font>8,341</font></td>
<td><font>7.95</font></td>
<td><font>6,817</font></td>
<td><font>107</font></td>
<td><font>78</font></td>
<td><font>6.1</font></td>
<td><font>71</font></td>
<td><font>4.6</font></td>
<td><font>8.4</font></td>
<td><font>44</font></td>
</tr><tr><td scope="row"><font>North  			 Dakota</font></td>
<td><font>648</font></td>
<td><font>6.36</font></td>
<td><font>5,797</font></td>
<td><font>128</font></td>
<td><font>63</font></td>
<td><font>5</font></td>
<td><font>62</font></td>
<td><font>4.5</font></td>
<td><font>5.8</font></td>
<td><font>64</font></td>
</tr><tr><td scope="row"><font>Ohio</font></td>
<td><font>17,467</font></td>
<td><font>10.38</font></td>
<td><font>6,336</font></td>
<td><font>146</font></td>
<td><font>62</font></td>
<td><font>4.5</font></td>
<td><font>62</font></td>
<td><font>5.3</font></td>
<td><font>7.3</font></td>
<td><font>43</font></td>
</tr><tr><td scope="row"><font>Oklahoma</font></td>
<td><font>4,876</font></td>
<td><font>9.92</font></td>
<td><font>8,198</font></td>
<td><font>108</font></td>
<td><font>90</font></td>
<td><font>3.1</font></td>
<td><font>85.8</font></td>
<td><font>4.2</font></td>
<td><font>6.5</font></td>
<td><font>30</font></td>
</tr><tr><td scope="row"><font>Oregon</font></td>
<td><font>5,314</font></td>
<td><font>11.05</font></td>
<td><font>5,372</font></td>
<td><font>100</font></td>
<td><font>59</font></td>
<td><font>1.9</font></td>
<td><font>55</font></td>
<td><font>5</font></td>
<td><font>4.7</font></td>
<td><font>72</font></td>
</tr><tr><td scope="row"><font>Pennsylvania</font></td>
<td><font>15,252</font></td>
<td><font>7.33</font></td>
<td><font>5,973</font></td>
<td><font>130</font></td>
<td><font>60</font></td>
<td><font>4.3</font></td>
<td><font>58</font></td>
<td><font>5.4</font></td>
<td><font>7.4</font></td>
<td><font>63</font></td>
</tr><tr><td scope="row"><font>Rhode  			 Island</font></td>
<td><font>1,437</font></td>
<td><font>8.54</font></td>
<td><font>6,149</font></td>
<td><font>151</font></td>
<td><font>61</font></td>
<td><font>5.8</font></td>
<td><font>67</font></td>
<td><font>6</font></td>
<td><font>7.6</font></td>
<td><font>33</font></td>
</tr><tr><td scope="row"><font>South  			 Carolina</font></td>
<td><font>3,498</font></td>
<td><font>6.69</font></td>
<td><font>6,091</font></td>
<td><font>100</font></td>
<td><font>69</font></td>
<td><font>4.8</font></td>
<td><font>65</font></td>
<td><font>5</font></td>
<td><font>8.2</font></td>
<td><font>34</font></td>
</tr><tr><td scope="row"><font>South  			 Dakota</font></td>
<td><font>557</font></td>
<td><font>4.78</font></td>
<td><font>5,524</font></td>
<td><font>118</font></td>
<td><font>62</font></td>
<td><font>6</font></td>
<td><font>61</font></td>
<td><font>4.6</font></td>
<td><font>6.3</font></td>
<td><font>23.4</font></td>
</tr><tr><td scope="row"><font>Tennessee</font></td>
<td><font>4,042</font></td>
<td><font>5.16</font></td>
<td><font>6,453</font></td>
<td><font>104</font></td>
<td><font>69</font></td>
<td><font>4</font></td>
<td><font>64</font></td>
<td><font>4.4</font></td>
<td><font>6.8</font></td>
<td><font>64</font></td>
</tr><tr><td scope="row"><font>Texas</font></td>
<td><font>21,224</font></td>
<td><font>10.01</font></td>
<td><font>6,983</font></td>
<td><font>141</font></td>
<td><font>71</font></td>
<td><font>4</font></td>
<td><font>75</font></td>
<td><font>5.2</font></td>
<td><font>6.8</font></td>
<td><font>49</font></td>
</tr><tr><td scope="row"><font>Utah</font></td>
<td><font>770</font></td>
<td><font>3.98</font></td>
<td><font>4,750</font></td>
<td><font>103</font></td>
<td><font>53</font></td>
<td><font>3.2</font></td>
<td><font>51</font></td>
<td><font>3.2</font></td>
<td><font>9.9</font></td>
<td><font>14.1</font></td>
</tr><tr><td scope="row"><font>Vermont</font></td>
<td><font>560</font></td>
<td><font>6.61</font></td>
<td><font>5,000</font></td>
<td><font>100</font></td>
<td><font>58</font></td>
<td><font>1</font></td>
<td><font>54</font></td>
<td><font>4</font></td>
<td><font>5.1</font></td>
<td><font>64</font></td>
</tr><tr><td scope="row"><font>Virginia</font></td>
<td><font>4,565</font></td>
<td><font>5.43</font></td>
<td><font>6,881</font></td>
<td><font>126</font></td>
<td><font>71</font></td>
<td><font>5</font></td>
<td><font>68</font></td>
<td><font>4.7</font></td>
<td><font>6.8</font></td>
<td><font>36</font></td>
</tr><tr><td scope="row"><font>Washington</font></td>
<td><font>6,139</font></td>
<td><font>8.74</font></td>
<td><font>5,575</font></td>
<td><font>117</font></td>
<td><font>58</font></td>
<td><font>3.6</font></td>
<td><font>55</font></td>
<td><font>4.4</font></td>
<td><font>6.4</font></td>
<td><font>47</font></td>
</tr><tr><td scope="row"><font>West  			 Virginia</font></td>
<td><font>2,308</font></td>
<td><font>6.95</font></td>
<td><font>6,392</font></td>
<td><font>102</font></td>
<td><font>70</font></td>
<td><font>3.6</font></td>
<td><font>65</font></td>
<td><font>5.2</font></td>
<td><font>5.9</font></td>
<td><font>40</font></td>
</tr><tr><td scope="row"><font>Wisconsin</font></td>
<td><font>5,502</font></td>
<td><font>7.21</font></td>
<td><font>5,612</font></td>
<td><font>105</font></td>
<td><font>64</font></td>
<td><font>3.6</font></td>
<td><font>60</font></td>
<td><font>4.6</font></td>
<td><font>5.8</font></td>
<td><font>34</font></td>
</tr><tr><td scope="row"><font>Wyoming</font></td>
<td><font>257</font></td>
<td><font>4.22</font></td>
<td><font>6,243</font></td>
<td><font>102</font></td>
<td><font>69</font></td>
<td><font>5.4</font></td>
<td><font>66</font></td>
<td><font>4.6</font></td>
<td><font>5.5</font></td>
<td><font>6</font></td>
</tr><tr><td colspan="11" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, 1996 and  			 1997</font></td>
</tr></table><p>The states exceeding Mississippi in per case spending are Oklahoma  		($8,198) and Arkansas ($8,023). These higher costs, like Mississippi's, can be  		explained by the higher number of days on the benefit (90 days each and 82  		days, respectively). The lower payments per day ($108 and $106 per day,  		respectively) suggests a high use of less intensive routine home care services.  		</p>
<p>States vary in the total days used, ranging from 90 days in Arkansas to  		51 days in Hawaii. Average enrollment on the benefit is a little over two  		months (65 days). These numbers support the contention that beneficiaries are  		enrolling in hospice very late in their terminal illness. This may be because  		of the difficulty in predicting death for certain cases, or physicians may be  		reluctant to broach the subject of death, beneficiaries may not be ready to  		waive their right to other treatments until later, or alternatively, it may be  		this point where the patient's discomfort reaches a level that requires  		hospice-oriented pain and symptom management with its stronger focus on  		palliative care outweighing any continuing interest in other treatments to  		restore health. Other states with longer lengths of enrollment include Kentucky  		(80 days), Maine (75 days), Mississippi (82 days), and North Carolina (78  		days).</p>
<p>The types of hospice services used also vary by geographic location.  		Some states, such as Maine, have a very high use of routine home care days, (74  		days per case, on average) but relatively lower use of inpatient services (6.8  		days compared to 7.7 days nationally.) Differences in the propensity to treat  		someone at home for intensive continuous home care rather than admit to an  		inpatient setting for that level of care also are noticeable across states.  		Louisiana, for example, has an average of 141 hours of continuous home care per  		patient, about 81 percent greater than the national average; but they have  		lower than average use of general inpatient care (5.7 days compared to 7.7  		days). This may be related to differences in general practice patterns.  		Louisiana, for example, ranks number one in per capita Medicare home health  		spending while it has relatively low institutional or skilled nursing facility  		use levels (Gage, Moon, and Chi, 1999). This suggests that practice patterns,  		in general, in Louisiana are more oriented towards home-based care than  		institutional care. Similarly, New York's slightly higher than average hospice  		costs are due to higher inpatient use that offsets the lower use per person  		rates of only 58 days enrolled in hospice. Again, this may reflect New York's  		high hospital use, in general. In contrast are South Dakota and Kansas, both of  		which have relatively lower spending and utilization than other states.</p>
<h3><a name="section3d" id="section3d">Medicare Expenditures and Service  		Use Prior to Hospice Enrollment</a></h3>
<p>Hospice benefits only begin once a beneficiary has decided to waive  		other treatments for their terminal illness. Prior to this stage, beneficiaries  		are receiving care for their illness with the intention of restoring health.  		This next section looks at the variation in the costs and types of Medicare  		benefits used (except physician and supplier services) in the six months prior  		to hospice election. These patterns are discussed for the total hospice  		population and for beneficiaries with some of the more frequently occurring  		hospice diagnoses.</p>
<table title="TABLE 9. Select Medicare Expenditures in 6 Months Prior to First Hospice Enrollment by Primary Diagnosis"><tr><td colspan="11"><font><b><a name="table9" id="table9">TABLE 9</a>. Select Medicare Expenditures  			 in 6 Months Prior to First Hospice Enrollment by Primary  			 Diagnosis</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font> </font></td>
<td colspan="2" scope="col"><font><b>Any Use*</b></font></td>
<td colspan="2" scope="col"><font><b>Inpatient</b></font></td>
<td colspan="2" scope="col"><font><b>SNF</b></font></td>
<td colspan="2" scope="col"><font><b>HHA</b></font></td>
<td colspan="2" scope="col"><font><b>OPD</b></font></td>
</tr><tr><td scope="col"><font><b>%</b></font></td>
<td scope="col"><font><b>$</b></font></td>
<td scope="col"><font><b>%</b></font></td>
<td scope="col"><font><b>$</b></font></td>
<td scope="col"><font><b>%</b></font></td>
<td scope="col"><font><b>$</b></font></td>
<td scope="col"><font><b>%</b></font></td>
<td scope="col"><font><b>$</b></font></td>
<td scope="col"><font><b>%</b></font></td>
<td scope="col"><font><b>$</b></font></td>
</tr><tr><td scope="row"><font>All</font></td>
<td><font>  82.8  </font></td>
<td><font>  13,488  </font></td>
<td><font>  61.2  </font></td>
<td><font>  12,857  </font></td>
<td><font>  16.2  </font></td>
<td><font>  7,332  </font></td>
<td><font>  37.6  </font></td>
<td><font>  3,147  </font></td>
<td><font>  71.1  </font></td>
<td><font>  1,300  </font></td>
</tr><tr><td scope="row"><font>Lung  			 Cancer</font></td>
<td><font>82.7</font></td>
<td><font>11,485</font></td>
<td><font>59.5</font></td>
<td><font>11,560</font></td>
<td><font>10.4</font></td>
<td><font>6,336</font></td>
<td><font>33.8</font></td>
<td><font>2,359</font></td>
<td><font>73.8</font></td>
<td><font>1,563</font></td>
</tr><tr><td scope="row"><font>Congestive  			 Heart Failure</font></td>
<td><font>84.5</font></td>
<td><font>15,356</font></td>
<td><font>69.7</font></td>
<td><font>12,659</font></td>
<td><font>24.1</font></td>
<td><font>7,479</font></td>
<td><font>49.8</font></td>
<td><font>3,776</font></td>
<td><font>68.1</font></td>
<td><font>681</font></td>
</tr><tr><td scope="row"><font>Prostate  			 Cancer</font></td>
<td><font>82.2</font></td>
<td><font>10,108</font></td>
<td><font>54.4</font></td>
<td><font>9,987</font></td>
<td><font>12.6</font></td>
<td><font>6,879</font></td>
<td><font>37.4</font></td>
<td><font>2,865</font></td>
<td><font>73.8</font></td>
<td><font>1,272</font></td>
</tr><tr><td scope="row"><font>Breast  			 Cancer</font></td>
<td><font>83.6</font></td>
<td><font>11,211</font></td>
<td><font>57.4</font></td>
<td><font>10,379</font></td>
<td><font>15.1</font></td>
<td><font>7,093</font></td>
<td><font>39.6</font></td>
<td><font>3,079</font></td>
<td><font>74.5</font></td>
<td><font>1,499</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Airway Obstruction</font></td>
<td><font>81</font></td>
<td><font>15,131</font></td>
<td><font>64.1</font></td>
<td><font>12,769</font></td>
<td><font>23.4</font></td>
<td><font>8,112</font></td>
<td><font>47.8</font></td>
<td><font>3,800</font></td>
<td><font>63.1</font></td>
<td><font>578</font></td>
</tr><tr><td scope="row"><font>Colon  			 Cancer</font></td>
<td><font>80.2</font></td>
<td><font>13,324</font></td>
<td><font>58.1</font></td>
<td><font>13,776</font></td>
<td><font>14</font></td>
<td><font>6,616</font></td>
<td><font>36.4</font></td>
<td><font>2,658</font></td>
<td><font>69.6</font></td>
<td><font>1,117</font></td>
</tr><tr><td scope="row"><font>Pancreas  			 Cancer</font></td>
<td><font>83.5</font></td>
<td><font>12,785</font></td>
<td><font>64.1</font></td>
<td><font>13,206</font></td>
<td><font>9.8</font></td>
<td><font>5,807</font></td>
<td><font>32.4</font></td>
<td><font>2,194</font></td>
<td><font>73.4</font></td>
<td><font>1,263</font></td>
</tr><tr><td scope="row"><font>Acute  			 Cerebrovascular Disease (CVA)  </font></td>
<td><font>81.6</font></td>
<td><font>14,731</font></td>
<td><font>65.1</font></td>
<td><font>11,911</font></td>
<td><font>27.3</font></td>
<td><font>8,435</font></td>
<td><font>33.3</font></td>
<td><font>4,312</font></td>
<td><font>62.7</font></td>
<td><font>834</font></td>
</tr><tr><td scope="row"><font>Rectosigmoid  			 Cancer</font></td>
<td><font>85.7</font></td>
<td><font>12,830</font></td>
<td><font>61.5</font></td>
<td><font>13,552</font></td>
<td><font>13.5</font></td>
<td><font>6,071</font></td>
<td><font>38.9</font></td>
<td><font>2,695</font></td>
<td><font>74.2</font></td>
<td><font>1,063</font></td>
</tr><tr><td scope="row"><font>Alzheimer's  			 Disease</font></td>
<td><font>75.9</font></td>
<td><font>9,126</font></td>
<td><font>43.5</font></td>
<td><font>9,250</font></td>
<td><font>17.2</font></td>
<td><font>7,638</font></td>
<td><font>25.8</font></td>
<td><font>4,586</font></td>
<td><font>61</font></td>
<td><font>672</font></td>
</tr><tr><td colspan="11" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, 1996 and  			 1997 * Any Use of Hospital Inpatient or Outpatient, SNF, or HHA services  			 (excludes physician and supplies)</font></td>
</tr></table><p>Almost all hospice enrollees used some Medicare Part A or outpatient  		service in the 6 months immediately preceding hospice enrollment (<a href="#table9">Table 9</a>). Total Medicare program costs for this period were,  		on average, $13,488. For beneficiaries whose primary hospice diagnosis was  		among the ten most common, pre-hospice program costs range from a low of $9,126  		per Alzheimer's case to $15,356 per case for patients with a primary diagnosis  		of congestive heart failure.</p>
<p>The variation in payments largely reflect the types of services used  		prior to hospice election. Inpatient hospital expenditures typically account  		for the largest share of Medicare spending, although the proportion using  		inpatient hospital services varies by condition. On average, 61.2 percent of  		all cases had an inpatient stay in the 6 months prior to hospice enrollment.  		This is down from the 68.6 percent who were previously hospitalized in 1990  		(Banaszak-Holl and Mor, 1995). At least half of all cases in 1996, except those  		with a primary diagnosis of AD, had an inpatient stay. Non-cancer cases, such  		as CHF, COPD, and stroke had a higher proportion of hospitalizations than the  		cancer cases although the majority of those cases were hospitalized also.  		Hospital spending levels ranged from over $13,500 for colon and rectosigmoid  		cancer cases to $9,250 for AD cases.<sup><font><a href="#note5">5</a></font></sup></p>
<p>Hospital outpatient services were the most common service prior to  		hospice enrollment; about 71.1 percent of all hospice enrollees used these  		services. Again, this varied by condition. Cancer cases had the highest  		proportions of outpatient users and the highest payments per service. This may  		be due to the availability of chemotherapy, laboratory work, x-rays and other  		related services being provided in these settings.</p>
<p>Another 16.2 percent used skilled nursing facility services prior to  		hospice enrollment. This was particularly true among the CHF, COPD, and stroke  		cases where approximately one-fourth of all cases were admitted to a SNF prior  		to electing hospice.</p>
<p>In general, beneficiaries who enroll in hospice have relatively high  		Medicare expenditures in the 6 months prior to enrollment in the palliative  		program. Average program payments for these enrollees are about twice as great  		as total hospice payments once they enroll. This is true for both the cancer  		and non-cancer cases. The one exception is with patients who have a primary  		hospice diagnosis of AD. These cases tend to have lower pre-hospice  		expenditures. This can be explained by looking at the types of services these  		cases use -- both prior to and following enrollment. The hospice enrollee with  		AD is using less of the expensive, inpatient institutional services. Their high  		hospice costs are due to the high number of days in the benefit unlike the  		patient with breast cancer who is using a high number of expensive inpatient  		days while on hospice.</p>
<p>These findings do not address whether hospice is a cost-effective  		alternative for end of life care. Instead they describe the high costs of care  		in the last few months of life even under the more palliative-oriented hospice  		benefit.</p>
<h3><a name="section3e" id="section3e">HMO Enrollees and Dual-Eligible  		Populations</a></h3>
<p>Two other groups of beneficiaries are of interest -- those who were  		previously enrolled in an HMO or dually-covered by Medicare and Medicaid (<a href="#table10">Table 10</a>). The HMO population is of interest because  		questions have been raised concerning HMO discharge practices to hospice. When  		an HMO enrollee elects hospice, the hospice becomes responsible for all costs  		associated with the terminal illness. The HMO only remains responsible for  		costs not associated with the terminal illness. Hence, they have a financial  		incentive to encourage their terminally ill beneficiaries to enroll in hospice.  		They also have an incentive from a quality of care standpoint. As argued by the  		HMO managers cited in the Fox study (1999a), terminally ill patients would  		receive more appropriate terminal care from a hospice than from their HMO  		providers.</p>
<table title="TABLE 10. Medicare Hospice Expenditures and Utilization by Select Characteristics"><tr><td colspan="4"><font><b>  <a name="table10" id="table10">TABLE 10</a>. Medicare Hospice  			 Expenditures and Utilization by Select  			 Characteristics  </b></font></td>
</tr><tr><td scope="col"><font><b>Characteristic</b></font></td>
<td scope="col"><font><b>  Percent  			 of  Users</b></font></td>
<td scope="col"><font><b>Medicare  Expenditures  </b></font></td>
<td scope="col"><font><b>  Hospice  			 Days  Utilized</b></font></td>
</tr><tr><td scope="row"><font>HMO  			 Enrollee</font></td>
<td><font>14.9%</font></td>
<td><font>$6,879*</font></td>
<td><font>60.4</font></td>
</tr><tr><td scope="row"><font>   Not Enrollee </font></td>
<td><font>85.2</font></td>
<td><font>$6,356</font></td>
<td><font>61.2</font></td>
</tr><tr><td scope="row"><font>Medicaid  			 Buyin  </font></td>
<td><font>16.1</font></td>
<td><font>$7,921*</font></td>
<td><font>76.0*</font></td>
</tr><tr><td scope="row"><font>   Not Buyin </font></td>
<td><font>83.9</font></td>
<td><font>$6,147</font></td>
<td><font>58.0</font></td>
</tr><tr><td colspan="4" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, and Part  			 B Supplier, 1996 and 1997 * Statistically significant at .000 or  			 less</font></td>
</tr></table><p>The results show that the differences in hospice payments between HMO  		enrollees and nonenrollees are significantly different ($6,879 compared to  		$6,356 per case). However, this is not due to a significantly different number  		of days being used by the HMO enrollees. This suggests that HMO enrollees who  		enter hospice are receiving more expensive levels of hospice care -- either  		inpatient level or continuous home care.</p>
<p>Another subgroup of interest is hospice enrollees who have been  		dually-covered by Medicaid at least once during the year before July 1, 1996.  		These dually-covered enrollees have significantly different payment and use  		patterns compared to those who were not dually-covered. Medicaid-covered  		enrollees have hospice payments that are 29 percent greater than enrollees who  		are not dually-covered. Similarly, their use levels are about 25 percent  		greater than the contrast group. This suggests the dually-eligible enrollees  		are using hospice for substantially longer periods than other enrollees. This  		may be due to differences in the population that is dually-covered and  		enrolling in hospice.</p>
<h3><a name="section3f" id="section3f">Multivariate Results Predicting  		Hospice Payments and Utilization Levels</a></h3>
<p>This next section measures the effects of beneficiary characteristics in  		predicting average hospice payments and use. Two OLS regression models are  		presented (<a href="#table11">Table 11</a>). The dependent variables are (1)  		logged total hospice payments and (2) logged total covered days. (A residual  		analysis suggested the dependent variable was not normally distributed.  		Transforming it by taking its log corrected this problem. The antilog of each  		coefficient is discussed in the text.) The independent variables include  		enrollee's age, and a set of dichotomous variables including gender, race  		defined as white or not, having Medicaid buyin coverage, being enrolled in an  		HMO during the 12 months prior to July 1, 1996, or having one of the 10 most  		frequently occurring primary diagnoses. These include malignant neo  		bronchial/lung (ICD-9 162), congestive heart failure (ICD-9 428), malignant  		neoplasm prostate (ICD-9 185), malignant neoplasm breast (female) (ICD-9 174),  		chronic airway obstruction (ICD-9 496), malignant neo colon (ICD-9 153),  		malignant neo pancreas (ICD-9 157), acute cerebrovascular disease or CVA (ICD-9  		436), malignant neo rectosigmoid jct (ICD-9 154), and Alzheimer's Disease  		(ICD-9 331.0). The payment and use models explain 1.6 percent and 1.4 percent,  		respectively of the variation in the dependent variables. While much of the  		unexplained variation in payment is related to utilization levels, payments and  		use are highly correlated. Therefore, both models are estimated independently  		and the explained variation in both is relatively small.</p>
<table title="TABLE 11. OLS Regression Results Predicting Medicare Hospice Expenditures and Days Utilized"><tr><td colspan="5"><font><b><a name="table11" id="table11">TABLE 11</a>. OLS Regression Results  			 Predicting Medicare Hospice Expenditures and Days Utilized</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font> </font></td>
<td colspan="2" scope="col"><font><b>Logged  			 Hospice  Expenditures Per Case  </b></font></td>
<td colspan="2"><font><b>Logged Hospice  Days Utilized Per  			 Case  </b></font></td>
</tr><tr><td scope="col"><font><b>  Coefficient  </b></font></td>
<td scope="col"><font><b>(S.E.)</b></font></td>
<td scope="col"><font><b>  Coefficient  </b></font></td>
<td scope="col"><font><b>(S.E.)</b></font></td>
</tr><tr><td scope="row"><font>Intercep</font></td>
<td><font>7.958*</font></td>
<td><font>  0.021  </font></td>
<td><font>3.177*</font></td>
<td><font>  0.022  </font></td>
</tr><tr><td scope="row"><font>Age</font></td>
<td><font>-0.003*</font></td>
<td><font>0.000</font></td>
<td><font>-0.003*</font></td>
<td><font>0.000</font></td>
</tr><tr><td scope="row"><font>Female</font></td>
<td><font>0.183*</font></td>
<td><font>0.005</font></td>
<td><font>0.184*</font></td>
<td><font>0.006</font></td>
</tr><tr><td scope="row"><font>White</font></td>
<td><font>-0.046*</font></td>
<td><font>0.008</font></td>
<td><font>-0.005</font></td>
<td><font>0.009</font></td>
</tr><tr><td scope="row"><font>Any  			 Medicaid</font></td>
<td><font>0.187*</font></td>
<td><font>0.007</font></td>
<td><font>0.213*</font></td>
<td><font>0.007</font></td>
</tr><tr><td scope="row"><font>Any  			 HMO</font></td>
<td><font>0.118*</font></td>
<td><font>0.007</font></td>
<td><font>-0.003</font></td>
<td><font>0.007</font></td>
</tr><tr><td scope="row"><font>Lung  			 Cancer</font></td>
<td><font>0.027*</font></td>
<td><font>0.007</font></td>
<td><font>0.086*</font></td>
<td><font>0.007</font></td>
</tr><tr><td scope="row"><font>Congestive  			 Heart Failure</font></td>
<td><font>0.013</font></td>
<td><font>0.011</font></td>
<td><font>0.021</font></td>
<td><font>0.011</font></td>
</tr><tr><td scope="row"><font>Prostate  			 Cancer</font></td>
<td><font>0.355*</font></td>
<td><font>0.012</font></td>
<td><font>0.417*</font></td>
<td><font>0.012</font></td>
</tr><tr><td scope="row"><font>Breast  			 Cancer</font></td>
<td><font>0.167*</font></td>
<td><font>0.013</font></td>
<td><font>0.205*</font></td>
<td><font>0.014</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Airway Obstruction</font></td>
<td><font>0.225*</font></td>
<td><font>0.013</font></td>
<td><font>0.244*</font></td>
<td><font>0.013</font></td>
</tr><tr><td scope="row"><font>Colon  			 Cancer</font></td>
<td><font>0.173*</font></td>
<td><font>0.014</font></td>
<td><font>0.205*</font></td>
<td><font>0.015</font></td>
</tr><tr><td scope="row"><font>Pancreas  			 Cancer</font></td>
<td><font>0.017</font></td>
<td><font>0.014</font></td>
<td><font>0.053*</font></td>
<td><font>0.015</font></td>
</tr><tr><td scope="row"><font>Acute  			 Cerebrovascular Disease (CVA)  </font></td>
<td><font>-0.292*</font></td>
<td><font>0.015</font></td>
<td><font>-0.463*</font></td>
<td><font>0.016</font></td>
</tr><tr><td scope="row"><font>Rectosigmoid  			 Cancer</font></td>
<td><font>0.184*</font></td>
<td><font>0.017</font></td>
<td><font>0.252*</font></td>
<td><font>0.017</font></td>
</tr><tr><td scope="row"><font>Alzheimer's  			 Disease</font></td>
<td><font>0.278*</font></td>
<td><font>0.017</font></td>
<td><font>0.317*</font></td>
<td><font>0.017</font></td>
</tr><tr><td colspan="5" scope="row"><font><b>SOURCE</b>: Analysis of Medicare Standard Analytic files, 1996 and  			 1997 R2=0.014 and 0.016* Statistically significant at .0001**  			 Statistically significant at .001</font></td>
</tr></table><p>Diagnoses are the best predictor of hospice payments among the variables  		included in these two models. The patients with the highest Medicare payments  		are those having prostate cancer (36 percent higher payments), Alzheimer's  		Disease (AD) (27 percent greater) and COPD (22.5 percent greater), all else  		equal. Stroke patients, on the other hand, have payments that are 29 percent  		lower than other patients, all else equal.</p>
<p>Demographics also are related to differences in total payments. Medicare  		payments for females are 18 percent greater than payments for male patients,  		after controlling for the top 10 primary diagnosis and some insurance coverage.  		Racial differences are noted also. Beneficiaries who are caucasian (White) have  		hospice payments that are 4.6 percent lower than for other beneficiaries.</p>
<p>Types of insurance coverage also appear to be related to per case  		payment levels. Program payments for dually-covered beneficiaries (Any  		Medicaid) are 18.7 percent higher than for their higher income counterparts.  		Beneficiaries who were enrolled in an HMO at some time during the year also  		have costs that are 11.8 percent greater than nonenrollee's hospice program  		payments, all else equal.</p>
<p>Similar differences are seen in the model predicting number of hospice  		days covered or used although there are slight differences between the two  		models. Diagnosis are still the best predictor of program use. Almost 42  		percent of the estimated use can be explained by having prostate cancer.  		Patients with stroke have significantly fewer covered days -- 46 percent --  		compared to others not in the model, all else equal. Similarly, patients with  		AD have 31.2 percent more days per case than other types of hospice enrollees.  		</p>
<p>Two differences between the models are in the significance of HMO  		enrollment and being white. These two groups do not have significantly  		different lengths of stay from their respective contrast groups. This suggests  		these two groups are not using more services than their counterparts although  		they may be using different types of services.</p>
<p>Medicaid buy-in coverage also is associated with longer lengths of stay.  		These dually-covered beneficiaries have 21.3 percent more days on hospice than  		those who were not dually-covered during the year, all else equal.</p>
<p>Differences in use by primary diagnosis remain similar to those found in  		the payment models. Beneficiaries with a primary diagnosis of CVA have 46  		percent fewer hospice days than other beneficiaries. And those with AD use 31.7  		percent more days than other patients. These findings reflect the differences  		shown in the bivariate analysis even after controlling for age and insurance  		coverage. As noted by Fox et al, patients with stroke tend to use fewer days of  		hospice care than other terminally ill patients. These findings are also  		consistent with those noted throughout the report -- that beneficiaries with a  		primary diagnosis of AD use hospice services much differently than others --  		staying on the benefit for a longer time, using more home care days, fewer  		continuous home care days, and more respite services, all else equal.</p>
<h2><a name="section4" id="section4">CONCLUSION</a></h2>
<p>These findings are useful for understanding the types of Medicare  		beneficiaries who are enrolling in hospice and how they are using it. The  		patient population is changing from the type who originally enrolled in the  		benefit when it was first established. Cancer patients still represent the  		majority of hospice enrollees but there is also a greater proportion of  		patients with chronic health care conditions.</p>
<p>As suggested by the findings, the patients with chronic heart and  		respiratory disease often use the benefit for shorter periods. This may be  		because there is such a short period between the onset of an exacerbated state  		of these illnesses and death. Alternatively, because it is so difficult to  		predict survival rates for these groups, physicians may be reluctant to suggest  		hospice enrollment particularly if they fear being charged with fraud if their  		patient survives over 6 months as was suggested in the earlier discussions in  		the first report in this series.</p>
<p>Questions were raised about the appropriateness of the Medicare  		eligibility guidelines during the discussions in the first part of this study.  		Specifically, the question was raised whether the requirement that the  		beneficiary have a life expectancy of 6 months or less was impeding access to  		hospice. While it is difficult to predict death, the average number of days  		used represent only one-third of the total days allowed (2 months compared to 6  		months). Another factor, which may have just as great an effect, may be a  		reluctance on the part of physicians and patients to discuss death. As a  		result, beneficiaries may be considering hospice only when their needs are so  		great that they require the services that generally distinguish hospice from  		other Medicare benefits -- integrated care management of pain and other  		symptoms and more generous personal care coverage. Hospice enrollment may be  		delayed until the patient's discomfort is sufficient to require the higher  		doses of pain medication, or as in the case of the beneficiary with Alzheimer's  		Disease, the need for greater social support or in-home care arises.</p>
<p>This study also showed there is substantial interstate variation in the  		hospice payment and utilization levels. Certain states, such as California,  		Florida, Texas, and New York have very large numbers of hospice enrollees  		suggesting it is a more common alternative for terminally ill beneficiaries.  		Hospice spending and utilization patterns were consistent with other  		state-level Medicare spending patterns in each state. For example, enrollees in  		Louisiana were less likely to use inpatient care and in New York they were more  		likely to be admitted to an inpatient stay. In Mississippi, the number of  		enrollees was relatively small (2,240 enrollees), but they used substantially  		higher than average numbers of hospice days prior to death. This reflected the  		higher use of both inpatient and home care services and resulted in the third  		highest payments per case in the nation.</p>
<p>Also of interest was the relative difference in Medicare expenditures  		prior to and following hospice enrollment. This is particularly true for the  		beneficiary with a primary diagnosis of Alzheimer's Disease since they had high  		levels of spending both prior to and subsequent to hospice enrollment. This  		population seems to be using hospice differently than others enrolled for end  		of life care. This may be due to a greater need for personal assistance rather  		than pain and symptom management in this population.</p>
<p>The multivariate models were also interesting as they showed the  		relative effect on payments and use levels after controlling for primary  		diagnosis. While they had low explanatory power (less than two percent of the  		variation in payments or use) they revealed differences in payments that  		largely reflected variations in use. These differences illustrate the  		heterogeneity of the hospice population.</p>
<h3><a name="section4a" id="section4a">Limitations and Data  		Constraints</a></h3>
<p>This analysis was limited in several ways. First, this report was  		intended to provide descriptive information on how Medicare's hospice benefit  		is being used. The sample is limited to hospice beneficiaries, and therefore,  		did not allow comparisons of differences in costs or use between terminally ill  		patients who did and did not enroll in hospice. Since this study was initiated  		to understand the role of hospice in nursing facilities limiting this part of  		the study sample to hospice beneficiaries was appropriate.</p>
<p>Second, there is little extant information on NF residents. The authors  		of this report initially attempted to develop national estimates of the  		proportion of hospice enrollees residing in nursing facilities using claims  		data. However, limitations with the method and differences in comparative  		definitions made it difficult to verify these estimates. To be conservative,  		these estimates have been omitted. The best estimates at this point, are  		presented in the two following reports which provide nursing facility  		population-based data for five states (Maine, Kansas, New York, South Dakota,  		and Mississippi). While these states are not representative as noted earlier,  		they provide an interesting and important case study on hospice in nursing  		facilities.</p>
<p>Better information is needed on hospice use by nursing facility  		residents -- how frequently nursing home residents use hospice, whether hospice  		use is more common in certain facilities, whether NF and community-based  		beneficiaries use different types of hospice services or different levels of  		resources, and what impact hospice has on the quality of care for terminally  		ill residents in nursing facilities.</p>
<p>The MDS data will be useful for developing national estimates of the  		frequency of hospice use in nursing homes and for providing some insights into  		the quality of hospice care provided to nursing home residents. While all  		states now must submit MDS data, they still may not provide a complete count of  		hospice use in nursing facilities for two reasons.</p>
<p>First, hospice enrollment does not automatically trigger a MDS  		assessment. The regulations require that a nursing facility must complete an  		assessment when a significant change in the resident's status occurs. According  		to the regulations a significant change is defined as, "a significant change in  		the resident's physical or mental condition.... [which] means a major decline  		or improvement in the resident's status that will not normally resolve itself  		without further intervention by staff or by implementing standard  		disease-related clinical interventions, that has an impact on more than one  		area of the resident's health status, and requires interdisciplinary review or  		revision of the care plan, or both" (42 CFR ch. IV, part 483, subpart b,  		section 483.20(b)(2)(ii)). However, hospice enrollment is one of the few  		situations where the care plan may be changed significantly without the patient  		undergoing multiple (or any) changes in condition. If hospice enrollment  		automatically triggered a MDS assessment, it could highlight for both the  		nursing facility and hospice staff, the new treatment focus and reduce the  		ambiguity between the two types of providers that was noted in the provider  		discussions.</p>
<p>A second reason the MDS may not completely identify nursing facility  		residents is that even if a facility understands the regulation as requiring an  		assessment, facilities must complete the assessment within 14 days. However,  		given that almost 25 percent of nursing home residents who begin using hospice  		subsequent to nursing home admission use 8 or fewer days of hospice services  		(<a href="http://aspe.hhs.gov/daltcp/reports/nufares.htm">Report 4</a>),  		beneficiaries may die before an assessment is complete. For this population, to  		identify beneficiaries' changing needs, and develop and implement needed plans  		of care, assessments need to be completed within a shorter time frame. </p>
<p>Another important data limitation is the dearth of information on  		whether beneficiaries residing in nursing facilities receive the same types and  		levels of hospice care (e.g., routine home care, respite, in-patient, or  		continuous home care) as those in the community. While this information can be  		gained by using the MDS data to identify NF residents and then contrasting  		their claims with nonNF residents as done in the  		<a href="http://aspe.hhs.gov/daltcp/reports/nufares.htm">4th report</a> in this  		study, utilization differences could be examined more efficiently by modifying  		the hospice claim to identify service location (nursing facility, other group  		home, individual residence). This would allow analysis of differences in use  		between the two populations without requiring the use of multiple datasets.</p>
<p>Understanding whether provider costs vary as a result of treating  		institutionalized enrollees is another important area requiring better data.  		Modifying the new cost reports to include a measure of the share of patients  		seen in nursing facilities would provide gross estimates of whether provider  		costs vary by differences in the proportion of institutionalized patients  		treated. While this still would not address differences in the levels and types  		of resources used by nursing facility and community-based residents, it may  		document whether hospices have lower costs for institutional patients. If they  		do, a more in-depth study may be needed to determine whether hospice per diem  		payments should be adjusted for treating institutional cases as suggested  		earlier by the OIG.</p>
<p>To fully understand whether these hospice patients receive different  		levels of care, and are treated by different types of professionals with  		varying lengths of visits would require a primary data collection effort. While  		this may be resource intensive to gather, it would allow disaggregation of the  		cost factors at the individual level to understand why cost varies as the  		beneficiary's place of residence changes. Such a study could also document the  		frequency of volunteer participation and post-burial family counseling which  		are two important covered hospices services that are largely undocumented.</p>
<p>More comprehensive information is needed on this group of terminally ill  		patients. Medicare payments are often complimented by state Medicaid or private  		insurance. Ensuring adequate benefits coordination and care coordination is an  		important issue in these austere times. National datasets on nursing facility  		residents are just becoming available as nursing homes are now required to  		submit electronic patient level data on all residents. This information will be  		crucial in understanding hospice as it is provided to beneficiaries residing in  		nursing homes at the end of their lifespan.</p>
<h2><a name="section5" id="section5">SUMMARY</a></h2>
<p>In summary, this information is intended to describe the current  		Medicare hospice program, who is using it, and how it is being used. The  		findings show that most beneficiaries are only using the benefit for  		approximately two months prior to death although this varies somewhat by  		diagnosis.</p>
<p>Hospice is a growing and important benefit, particularly for those who  		require specialized pain and symptom management. It is intended to provide  		managed palliative or comfort care at the end of life. This is particularly  		important under the current Medicare fee-for-service program which lacks  		coverage for this type of critical care needed by at least the five percent of  		beneficiaries who die each year. Understanding who uses the benefit and how it  		is used is important for understanding its role in serving the Medicare  		population.</p>
<h2><a name="references" id="references">REFERENCES</a></h2>
<p>Banaszak-Holl J, Mor V. (1995): Hospice report: The impact of changing  		Medicare coverage on hospice beneficiaries. Report prepared in connection with  		HCFA contract #500-89-0063 to Abt Associates, Inc.</p>
<p>Fox, Peter, (1999a): End of Life Care in Managed Care Organizations.  		<i>American Association of Retired Persons</i>, Public Policy Paper.  		Washington, DC.</p>
<p>Fox, E., Landrum-McNiff, K., Zhong, Z., Dawson, N., Wu, A., and Lynn, J.  		(1999b): Evaluation of Prognostic Criteria for Determining Hospice Eligibility  		in Patients with Advanced Lung, Heart, or Liver Disease. <i>Journal of the  		American Medical Association</i>, 282(17):1638-1645.</p>
<p>Gage, B., Moon, M., and Chi, S. (1999): State Variation in Medicare  		Spending. <i>Health Care Financing Review</i>. Winter 1999: forthcoming.</p>
<p>Rosenberg, H., Ventura, S., Maurer, J., et al. Births and Deaths: United  		States, 1995. Monthly Vital Statistics Report: 45(3) supp2. P.31. Hyattsville,  		Md.:NCHS. 1996.</p>
<h2><a name="notes" id="notes">NOTES</a></h2>
<ol><li>
<p><a name="note1" id="note1">Physician</a> claims were excluded due to  			 difficulties accessing data.</p>
</li>
<li>
<p><a name="note2" id="note2">Omitted</a> were Part B payments for physician  			 services not covered by the hospice, i.e., non-hospice physician services.</p>
</li>
<li>
<p><a name="note3" id="note3">Technically,</a> these enrollees without routine  			 home care days also could have been admitted directly to respite services, but  			 this is highly improbable according to the Hospice Association of America.</p>
</li>
<li>
<p><a name="note4" id="note4">See</a> Gage, Moon, and Chi, 1999 for a discussion  			 of state variations in the Medicare population</p>
</li>
<li>
<p><a name="note5" id="note5">AD</a> patient's average payment for any service is  			 slightly lower than the average payment for inpatient services because the  			 inpatient average is based only on those who had an inpatient admission whereas  			 the denominator in the "any use" average is weighted by AD patients who were  			 not hospitalized prior to hospice admission.</p>
</li>
</ol><hr /><h3>REPORTS AVAILABLE</h3>
<p>The goal of ASPE's Medicare Hospice Benefit study was to provide general  		information on the role of the Medicare hospice benefit and more specific  		information about how end of life care is provided to institutionalized  		beneficiaries. Six reports wereproduced from this study: </p>
<p><b>Synthesis and Analysis of Medicare's Hospice Benefit: Executive  		Summary and Recommendations</b> (report 1) briefly summarizes the methods used  		for each report and the findings and recommendations that emerged from each of  		the following reports under this study.HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2000/samhbes.htm">http://aspe.hhs.gov/daltcp/reports/2000/samhbes.htm</a>  		PDF   <a href="http://aspe.hhs.gov/daltcp/reports/2000/samhbes.pdf">http://aspe.hhs.gov/daltcp/reports/2000/samhbes.pdf</a>  		</p>
<p><b>Important Questions for Hospice in the Next Century</b> (report 2)  		synthesizes the literature related to the Medicare hospice benefit and  		summarizes discussions with key informants on the use of hospice in nursing  		homes. Executive Summary   <a href="http://aspe.hhs.gov/daltcp/reports/impquees.htm">http://aspe.hhs.gov/daltcp/reports/impquees.htm</a>  		HTML   <a href="http://aspe.hhs.gov/daltcp/reports/impques.htm">http://aspe.hhs.gov/daltcp/reports/impques.htm</a>  		PDF   <a href="http://aspe.hhs.gov/daltcp/reports/impques.pdf">http://aspe.hhs.gov/daltcp/reports/impques.pdf</a>  		</p>
<p><b>Medicare's Hospice Benefit: Use and Expenditures, 1996 Cohort</b>  		(report 3) analyzes Medicare utilization and payments for hospice users in  		1996. HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2000/96useexp.htm">http://aspe.hhs.gov/daltcp/reports/2000/96useexp.htm</a>  		PDF   <a href="/system/files/pdf/73406/96useexp.pdf">http://aspe.hhs.gov/daltcp/reports/2000/96useexp.pdf</a>  		</p>
<p><b>Use of Medicare's Hospice Benefit by Nursing Facility Residents</b>  		(report 4) examines differences in hospice utilization and expenditures as a  		function of when nursing facility residents started using hospice services  		(i.e., before or during a nursing home stay).HTML   <a href="http://aspe.hhs.gov/daltcp/reports/nufares.htm">http://aspe.hhs.gov/daltcp/reports/nufares.htm</a>PDF   <a href="http://aspe.hhs.gov/daltcp/reports/nufares.pdf">http://aspe.hhs.gov/daltcp/reports/nufares.pdf</a>  		</p>
<p><b>Outcomes and Utilization for Hospice and Non-Hospice Nursing Facility  		Decedents</b> (report 5) compares pain management and types of services  		provided to dying nursing home residents receiving hospice compared to other  		dying residents who did not receive hospice.HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2000/oututil.htm">http://aspe.hhs.gov/daltcp/reports/2000/oututil.htm</a>  		PDF   <a href="http://aspe.hhs.gov/daltcp/reports/2000/oututil.pdf">http://aspe.hhs.gov/daltcp/reports/2000/oututil.pdf</a>  		</p>
<p><b>Hospice Benefits and Utilization in the Large Employer Market</b>  		(report 6) reports on how hospice services are provided by 52 large employers  		and used by their employees, and identifies alternative approaches to designing  		and administering hospice benefits. Executive Summary   <a href="http://aspe.hhs.gov/daltcp/reports/empmktes.htm">http://aspe.hhs.gov/daltcp/reports/empmktes.htm</a>  		HTML   <a href="http://aspe.hhs.gov/daltcp/reports/empmkt.htm">http://aspe.hhs.gov/daltcp/reports/empmkt.htm</a>  		PDF   <a href="http://aspe.hhs.gov/daltcp/reports/empmkt.pdf">http://aspe.hhs.gov/daltcp/reports/empmkt.pdf</a>  		</p>
<hr /><p>To obtain a printed copy of this report, send the full report title and  		your mailing information to:</p>
<blockquote><p>U.S. Department of Health and Human ServicesOffice of Disability,  		  Aging and Long-Term Care PolicyRoom 424E, H.H. Humphrey Building200  		  Independence Avenue, S.W.Washington, D.C.  		  20201FAX:  202-401-7733Email:  <a href="mailto: webmaster.DALTCP@hhs.gov">webmaster.DALTCP@hhs.gov</a></p>
</blockquote>
<hr /><p class="lastupdated"><b>RETURN TO:</b> </p>
<p class="lastupdated">Office of Disability, Aging and  		Long-Term Care Policy (DALTCP) Home [<a href="http://aspe.hhs.gov/_/office_specific/daltcp.cfm">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a>]Assistant  		Secretary for Planning and Evaluation (ASPE) Home [<a href="http://aspe.hhs.gov">http://aspe.hhs.gov</a>]U.S. Department of  		Health and Human Services Home [<a href="http://www.hhs.gov">http://www.hhs.gov</a>]</p>

  <div class="download_report">
    
                        <div class="pdf-prev">
                <img src="https://aspe.hhs.gov/system/files/pdfpreview/5ab4996fdd8b16abf06025872e79e05e.png" alt="Preview" title="Preview" />            </div>
                <a class="btn btn-sm btn-default download-file"
           href="https://aspe.hhs.gov/system/files/pdf/73406/96useexp.pdf">Download</a>

        <p class="download_title">&quot;96useexp.pdf&quot;
            (pdf,
            1.83Mb)</p>
        <p>Note: Documents in PDF format require the <a href="http://www.adobe.com/products/acrobat/readstep2.html">Adobe
                Acrobat Reader&reg;</a>. If you experience problems with PDF documents, please <a
                href="http://www.adobe.com/products/acrobat/readstep2.html">download the latest version of the
                Reader&reg;</a>
        </p>
    </div>
<div class="group-tags"><div class="field-label">Tags:&nbsp;</div><a href="/terms/publications-2">Publications</a><a href="/terms/hospice-0">Hospice</a><a href="/terms/disability-aging-and-long-term-care-research">Disability, Aging and Long-Term Care Research</a><a href="/terms/health-services-formal">Health Services, Formal</a></div>  </div>

      <footer>
          </footer>
  
    <div id="block-webform-client-block-158521" class="widget block block-webform" >
  
      
  <div id="webform-ajax-wrapper-158521"><form class="webform-client-form webform-client-form-158521" action="/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" method="post" id="webform-client-form-158521" accept-charset="UTF-8"><div><div class="webform-progressbar">
  

  
  </div>
<div  class="form-item webform-component webform-component-radios webform-component--was-this-page-helpful">
  <label for="edit-submitted-was-this-page-helpful">Was this page helpful? <span class="form-required" title="This field is required.">*</span></label>
 <div id="edit-submitted-was-this-page-helpful" class="form-radios"><div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-1" name="submitted[was_this_page_helpful]" value="1" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-1">Yes </label>

</div>
<div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-2" name="submitted[was_this_page_helpful]" value="0" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-2">No </label>

</div>
</div>
</div>
<input type="hidden" name="details[sid]" />
<input type="hidden" name="details[page_num]" value="1" />
<input type="hidden" name="details[page_count]" value="4" />
<input type="hidden" name="details[finished]" value="0" />
<input type="hidden" name="form_build_id" value="form-wwA7bohLs0W5tMgrSe_cjYGcM5qAMUHIT37FP4IDi6s" />
<input type="hidden" name="form_id" value="webform_client_form_158521" />
<input type="hidden" name="webform_ajax_wrapper_id" value="webform-ajax-wrapper-158521" />
<div class="form-actions"><input class="webform-next button-primary btn btn-default form-submit" type="submit" id="edit-webform-ajax-next-158521" name="op" value="Next &gt;" /></div>
<div class="is-useful-disclaimer"> <a href="/%23" class="" title="Survey Disclaimer" data-toggle="modal" data-target="#disclamerModal">Form Approved OMB# 0990-0379 Exp. Date 8/31/2017</a></div>
<div class="modal fade" id="disclamerModal" tabindex="-1" role="dialog" aria-labelledby="disclamerModalLabel">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
        <h2 class="modal-title" id="disclamerModalLabel">Survey Disclaimer</h2>
      </div>
      <div class="modal-body">
         According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0379. The time required to complete this information collection is estimated to average 5 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.      </div>
    </div>
  </div>
</div></div></form></div>
  </div> <!-- /.block -->
<meta  itemscope="" itemid="https://aspe.hhs.gov/pdf-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" itemref="md1" /><meta  itemscope="" itemid="https://aspe.hhs.gov/basic-report/medicares-hospice-benefit-use-and-expenditures-1996-cohort" itemref="md2 md3 md5 md7 md9 md11" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/publications-2" id="md5" itemref="md4" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/hospice-0" id="md7" itemref="md6" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/disability-aging-and-long-term-care-research" id="md9" itemref="md8" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/health-services-formal" id="md11" itemref="md10" />              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
      </div>

          </div>
    
    
      </div>
    


      <footer  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Footer">     

        
                  
        
                  
        
                  
        
                  
        
                                    <div  id="footer_sitemap-footer_sitemap" class="col-sm-6 col-md-6 col-lg-4 ">
                          
                              <div id="block-footer-sitemap-footer-sitemap" class="widget block block-footer-sitemap" >
  
      
  <div id="footer-sitemap" class="clearfix">
  <div class="fs-block-content"><div class="menu-footer-utility"><ul class="footer_links_menu-footer-utility total-items-2 parent-items-0 single-items-0"><li class="menu-5021 depth-1 total-children-8 parent-children-0 single-children-8  first"><a href="/" title="look at ASPE Home" class="fs-root-link">ASPE Home</a><ul class="footer_links_menu-footer-utility total-items-8 parent-items-0 single-items-0"><li class="menu-5026 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/" title="look at HHS Home">HHS Home</a></li>
<li class="menu-66281 depth-1 fs-no-children"><a href="http://www.usa.gov/" title="look at USA.gov">USA.gov</a></li>
<li class="menu-66316 depth-1 fs-no-children"><a href="https://oig.hhs.gov/" title="look at Office of the Inspector General">Office of the Inspector General</a></li>
<li class="menu-66321 depth-1 fs-no-children"><a href="http://www.whitehouse.gov" title="look at The White House">The White House</a></li>
<li class="menu-5046 depth-1 fs-no-children"><a href="http://www.hhs.gov/Accessibility.html" title="look at Accessibility">Accessibility</a></li>
<li class="menu-66326 depth-1 fs-no-children"><a href="http://www.hhs.gov/about/budget/index.html" title="look at Budget/Performance">Budget/Performance</a></li>
<li class="menu-2551 depth-1 fs-no-children"><a href="http://www.hhs.gov/Privacy.html" title="look at Privacy Policy">Privacy Policy</a></li>
<li class="menu-197776 depth-1 fs-no-children  last"><a href="https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html" title="Nondiscrimination Notice">Nondiscrimination Notice</a></li>
</ul></li>
<li class="menu-5051 depth-1 total-children-4 parent-children-0 single-children-4  last"><a href="http://www.hhs.gov/foia/" title="look at FOIA" class="fs-root-link">FOIA</a><ul class="footer_links_menu-footer-utility total-items-4 parent-items-0 single-items-0"><li class="menu-5056 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/open/recordsandreports/plainwritingact/index.html" title="look at Plain Writing Act">Plain Writing Act</a></li>
<li class="menu-5061 depth-1 fs-no-children"><a href="http://www.hhs.gov/asa/eeo/no_fear_bullet_3.html" title="look at No Fear Act">No Fear Act</a></li>
<li class="menu-5066 depth-1 fs-no-children"><a href="http://www.hhs.gov/Disclaimer.html" title="look at Disclaimers">Disclaimers</a></li>
<li class="menu-2546 depth-1 fs-no-children  last"><a href="http://www.hhs.gov/plugins.html" title="look at Viewers &amp; Players">Viewers &amp; Players</a></li>
</ul></li>
</ul></div>
</div>
</div>

  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-5 " id="stability_cms-contact_us">
                          
                              <div id="block-stability-cms-contact-us" class="widget block block-stability-cms" >
  
      
  <div class="contacts-widget widget widget__footer">
	<div class="widget-content">
		<ul class="contacts-info-list">
      			<li>
<!--				<i class="fa fa-map-marker">Address</i>-->
                <div class="info-icons">
                    <img  alt="map" class= 'map-icons' src="/sites/all/themes/stability/stability_aspe/images/map.png"/>
                </div>
                <div class="info-item">
					Assistant Secretary for Planning and Evaluation, Room 415F<br />
U.S. Department of Health and Human Services<br />
200 Independence Avenue, SW<br />
Washington, D.C. 20201				</div>
			</li>
            			<li>
<!--				<i class="fa fa-phone">phone</i>-->
                <div class="info-icons">
                    <img alt="phone" src="/sites/all/themes/stability/stability_aspe/images/phone.png"/>
                </div>
				<div class="info-item">
					+1 202.690.7858				</div>
			</li>
            			<li>
<!--				<i class="fa fa-envelope">email</i>-->
                <div class="info-icons">
                    <img alt="mail" src="/sites/all/themes/stability/stability_aspe/images/mail-white.png"/>
                </div>
				<span class="info-item">
					<a href="mailto:osaspeinfo@hhs.gov">osaspeinfo@hhs.gov</a>
				</span>
			</li>
      			                					</ul>
	</div>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-3 " id="footer">
                          
                              <div id="block-block-36" class="widget block block-block" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Sign-up</span> for Email Updates</h3>
		</div>
    
  <div class="email_updates">
<button class="btn btn-default" name="subscribe-button" type="submit" value="subscribe">subscribe</button>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-12 " id="menu-menu-footer-language-menu">
                          
                              <div id="block-menu-menu-footer-language-menu" class="widget block block-menu" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Language</span> Assistance Available</h3>
		</div>
    
  <ul class="menu"><li class="first expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#spanish" title="Español">Español</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#chinese" title="繁體中文">繁體中文</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#vietnamese" title="Tiếng Việt">Tiếng Việt</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#korean" title="한국어">한국어</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#tagalog" title="Tagalog">Tagalog</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#russian" title="Русский">Русский</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#arabic" title="العربية">العربية</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#creole" title="Kreyòl Ayisyen">Kreyòl Ayisyen</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#french" title="Français">Français</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#polish" title="Polski">Polski</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#portuguese" title="Português">Português</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#italian" title="Italiano">Italiano</a></li>
</ul></li>
<li class="last expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#german" title="Deutsch">Deutsch</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#japanese" title="日本語">日本語</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#farsi" title="فارسی">فارسی</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#english" title="English">English</a></li>
</ul></li>
</ul>
  </div> <!-- /.block -->
              
                          </div>
                              
        
      </div>

          </div>
    
    
      </footer>
    

    <!--/PAGEWATCH-->
    <div class="footer-copyright">
      <div class="container">
        <div class="row">
          <div class="col-sm-6 col-md-4">
                        </div>
          <div class="col-sm-6 col-md-8">
            <div class="social-links-wrapper">
              <span class="social-links-txt">Connect with us</span>
              <ul class="social-links social-links__dark">
                                                  <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="/sites/all/themes/stability/stability_aspe/images/tw-grey.png"/></a></li>
                                <!--                --><!--                  <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin-grey.png"/></a></li>-->
<!--                -->
                                                              </ul>
            </div>
          </div>
        </div>
      </div>
    </div>

  </div>
</div>  <script type="text/javascript" src="/sites/default/files/advagg_js/js__VWRymaMz6HfrhnrcJNGcDiSvLVrvhaXvBa7nrBYy8gc__jntPwP3D6myJZH1jW19fXrk5cYMHGRL8NQION22VSEA__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5486d15a696bff0c"></script>
<script type="text/javascript" src="/sites/default/files/advagg_js/js__g6mKbcakHxQkz4ZHYaxdO_xqONINvRMgsHh1zAK-fr0__ATHtEmHaeZ0jidpGU22EkhmPDBSgjD8z0bVDQMI-BIY__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="/sites/default/files/advagg_js/js__KUp4PrfOt9BSXUVl8Ctb3dhCMBe4MNVMeb4Gyorx8yY__7g4BeXscCIZAfuu1vxsCj2RIemg-eEK0QpChP9LDmFQ__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="/sites/default/files/advagg_js/js__PNjAgubM_3xXRLp4uLsYnv8wQAdT89-RYkSPxT6T45c__rFQwFK4pA5ZaWZSF7FPTfKbbpus0h-5IS8ayrNZGrb4__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="/sites/default/files/advagg_js/js__vQiLul2UcfC4nBAR09mhYVBYzRmiNDm2dj3GgSubV38__w84oZe-ZODKe7XnnlbrjV4IWHISOy4PioFEMVgx9hZo__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="/sites/default/files/advagg_js/js__QJw3g0kOdwsv4twSZLP931zBzsHy50VEHpEN_znIitQ__A6QOuWXElDipBM2iChbWhjAAt3KlUwZ-jODoxdpbwiw__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"stability_aspe","theme_token":"DBiFGN_6U_9_9rA99teuFWgr1TEv04LFDKI_vVmK1MI","jquery_version":"1.10","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.messages.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/footable.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/aspe_nodes.admin.css":1,"sites\/all\/modules\/custom\/aspe_views\/theme\/css\/aspe_views.admin.css":1,"sites\/all\/modules\/forked\/book\/book.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_api\/date.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/footer_sitemap\/footer_sitemap.css":1,"modules\/node\/node.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/extlink.css":1,"profiles\/openpublic\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.css":1,"profiles\/openpublic\/modules\/contrib\/ctools\/css\/ctools.css":1,"profiles\/openpublic\/modules\/contrib\/panels\/css\/panels.css":1,"profiles\/openpublic\/modules\/contrib\/webform\/css\/webform.css":1,"sites\/default\/files\/css\/follow.css":1,"sites\/all\/themes\/stability\/css\/bootstrap.min.css":1,"sites\/all\/themes\/stability\/css\/fonts\/font-awesome\/css\/font-awesome.min.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.theme.css":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/magnific-popup.css":1,"sites\/all\/themes\/stability\/vendor\/mediaelement\/mediaelementplayer.css":1,"sites\/all\/themes\/stability\/css\/theme.css":1,"sites\/all\/themes\/stability\/css\/theme-elements.css":1,"sites\/all\/themes\/stability\/css\/animate.min.css":1,"sites\/all\/themes\/stability\/css\/skins\/red.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/slideshow.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/font-main.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/styleless.less":1,"sites\/all\/themes\/stability\/css\/skins\/blue.css":1},"js":{"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.10\/jquery.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/aspe\/theme\/js\/aspe.login-confirm.js":1,"sites\/all\/modules\/custom\/aspe_report\/modules\/aspe_databooks\/js\/aspe_databooks.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.highcharts.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/libraries\/datatables\/dataTables.min.js":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.min.js":1,"sites\/all\/libraries\/highcharts\/highcharts.js":1,"sites\/all\/libraries\/highcharts\/highcharts.exporting.js":1,"sites\/all\/libraries\/highcharts\/highcharts.map.js":1,"sites\/all\/libraries\/highcharts\/highcharts.us-all.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.footable.js":1,"http:\/\/s7.addthis.com\/js\/300\/addthis_widget.js#pubid=ra-5486d15a696bff0c":1,"misc\/progress.js":1,"profiles\/openpublic\/modules\/contrib\/webform\/js\/webform.js":1,"profiles\/openpublic\/modules\/contrib\/field_group\/field_group.js":1,"sites\/all\/themes\/stability\/vendor\/jquery-migrate-1.2.1.min.js":1,"sites\/all\/themes\/stability\/vendor\/bootstrap.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flexnav.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.hoverIntent.minified.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flickrfeed.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.sloppy-masonry.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.imagesloaded.min.js":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/jquery.magnific-popup.js":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.fitvids.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.appear.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.stellar.min.js":1,"sites\/all\/themes\/stability\/vendor\/snap.svg-min.js":1,"sites\/all\/themes\/stability\/js\/custom.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/aspe.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/html5shiv.min.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/main-menu.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/keyboard-control.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tabBehavior.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tileStringTrimmer.js":1}},"webform":{"conditionals":{"webform-client-form-158521":{"ruleGroups":[],"sourceMap":[],"values":[]}}},"ajax":{"edit-webform-ajax-next-158521":{"callback":"webform_ajax_callback","wrapper":"webform-ajax-wrapper-158521","progress":{"message":"","type":"throbber"},"event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Next \u003E"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/basic-report\/medicares-hospice-benefit-use-and-expenditures-1996-cohort":true},"extlink":{"extTarget":"_blank","extClass":0,"extLabel":"(link is external)","extImgClass":0,"extSubdomains":0,"extExclude":"([a-z0-9]\\.gov)","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":"This website contains links to other federal and state agencies and private organizations. The Department of Health and Human Services (HHS) cannot attest to the accuracy of information provided by these nonfederal website links. Linking to nonfederal sites does not constitute an endorsement by HHS or any of its employees of the sponsors or the information and products presented on the sites. You will be subject to the destination site\u0027s privacy policy when you leave the ASPE website.\r\n\r\nThank you for visiting aspe.hhs.gov!","mailtoClass":0,"mailtoLabel":"(link sends e-mail)"},"stability":{"flickr_id":"52617155@N08","logo_sticky":"28"},"field_group":{"div":"full","hidden":"full"}});
//--><!]]>
</script>
  <script type="text/javascript">
<!--//--><![CDATA[//><!--
var addthis_config={pubid:"ra-5486d15a696bff0c",ui_click:false}
//--><!]]>
</script>


  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"e4837db659","applicationID":"10708002","transactionName":"MwNaZBRSXEtXB0BdWQpJeVMSWl1WGQpbUFM7FllXA2xEUVMT","queueTime":0,"applicationTime":1603,"atts":"H0RZElxIT0U=","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
